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General Experimental Details  
Unless otherwise noted, all reactions were magnetically stirred and performed under an atmosphere of 
inert gas (Ar or N2) using standard Schlenk techniques. The reactions were carried out in oven-dried 
glassware (200 °C oven temperature). External bath temperatures were used to record all reaction mixture 
temperatures. Diethyl ether (Et2O) and tetrahydrofuran (THF) were distilled prior to use under an 
atmosphere of N2 from sodium and benzophenone, triethylamine (NEt3) from calcium hydride. N,N-
dimethylformamide (DMF), toluene and methanol (MeOH) were purchased from Acros Organics as 
'extra dry' reagents under inert gas atmosphere and over molecular sieves. Solvents for flash column 
chromatography and crystallization experiments were purchased in technical grade and distilled under 
reduced pressure prior to use. Degassed solvents were degassed under N2 atmosphere by using either 
three successive freeze-pump-thaw cycles or by purging the solvent for 30 min with N2. Petroleum ether 
(PE) refers to fractions of iso-hexanes which boil between 40 and 80 °C. All other reagents were 
purchased from commercial sources and used without further purification. 
Chromatography. Analytical thin-layer chromatography (TLC) was performed on pre-coated glass plates 
(silica gel 60 F254) from Merck, and visualized by exposure to ultraviolet light (UV, 254 nm) and by 
staining with aqueous acidic ceric ammonium molybdate(IV) (CAM) solution. Flash column 
chromatography was performed using Merck silica gel (40−63 µm particle size). 
NMR Spectroscopy. Proton nuclear magnetic resonance (1H NMR) spectra were recorded in deuterated 
chloroform (CDCl3) in 5 mm tubes on a Bruker Avance III HD 400 MHz spectrometer equipped with a 
CryoProbe™, a Varian VXR400 S spectrometer, a Bruker AMX600 spectrometer or a Bruker Avance III 
HD 800 MHz spectrometer equipped with a CryoProbe™ in deuterated solvents at room temperature. 
Chemical shifts (δ scale) are expressed in parts per million (ppm) and are calibrated using residual protic 
solvent as an internal reference (CHCl3: δ = 7.26 ppm).[1] Data for 1H NMR spectra are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constants (Hz), integration). Couplings are 
expressed as: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet or combinations thereof. 
Carbon nuclear magnetic resonance (13C NMR) spectra were recorded at 75, 100 and 150 MHz, 
respectively. Carbon chemical shifts (δ scale) are also expressed in parts per million (ppm) and are 
referenced to the central carbon resonances of the solvents (CDCl3: δ = 77.16 ppm). In order to assign 
the 1H and 13C NMR spectra, a range of 2D NMR experiments (COSY, HSQC, HMBC, NOESY) were 
used as appropriate. The numbering of the proton and carbon atoms does not correspond to the IUPAC 
nomenclature. Diastereotopic protons in the 1H NMR spectra are referenced with a and b, nomenclature 
is arbitrarily and does not correspond to the spin system. 
High performance liquid chromatography (HPLC). HPLC was performed with HPLC grade solvents 
and deionized H2O that was purified on a TKA MicroPure H2O purification system. All solvents were 
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degassed with helium gas prior to use. Unless noticed otherwise, all experiments were carried out at room 
temperature. 
Analytical HPLC spectra were recorded on a ultra-high performance liquid chromatography (UHPLC) 
system from the Agilent 1260 Infinity series (1260 degasser, 1260 Binary Pump VL, 1260 ALS auto 
sampler, 1260 TCC thermostated column compartment, 1260 DAD diode array detector), which was 
computer-controlled through Agilent ChemStation software. 
Chiral HPLC spectra were recorded on a high performance liquid chromatography (HPLC) system from 
the Shimadzu 20A series (DGU-20A3R degasser, LC-20AD Binary Pump VL, SIL-20AHT autosampler, 
CTO-20A thermostated column compartment, SPD-M20A DAD diode array detector), which was 
computer controlled through Shimadzu LabSolutions Software (Version 5.42 SP5). Enantiomeric excess 
(ee) was calculated by using the following equation; m1 refers to the integral of the major peak and m2 to 
the integral of the minor peak: 
𝑒𝑒 =   𝑚! −𝑚!𝑚!  +  𝑚!  ∙ 100%		
High-resolution mass spectrometry (HRMS). A Varian MAT CH7A mass spectrometer was used to 
obtain high-resolution electron ionization (EI) mass. High-resolution electronspray (ESI) mass spectra 
were recorded on a Varian MAT 711 MS spectrometer operation in either positive or negative ionization 
modes. 
Infrared spectroscopy (IR).  Infrared spectra (IR) were recorded on a Perkin Elmer Spectrum BX II 
(FTIR System) equipped with an attenuated total reflection (ATR) measuring unit. IR data is reported in 
frequency of absorption (cm‒1). The IR bands are characterized as: w = weak, m = medium, s = strong, 
br = broad, or combinations thereof.  
Melting points (mp). Melting points were measured on a Büchi Melting Point B-540 or SRS MPA120 
EZ-Melt apparatus and are uncorrected. 
Optical rotation. Perkin-Elmer 241 or Krüss P8000-T polarimeter were used to measure optical rotation 
at the Sodium D-line (589 nm) at the given temperature (T in °C) and concentrations (c in g/100 mL) 
using spectroscopic grade solvents. The measurements were carried out in a cell with a path length (d) of 
0.5 dm. Specific rotations were calculated using the following equation: 
α ! = α𝑐 ∙ 𝑑  10!! ∙ deg ∙ cm!g 	
All yields are isolated unless otherwise specified. 
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Experimental Procedures 
7,8-Dimethoxy-1,2,3,4-tetrahydronaphtalen-2-one (6)  
 
Oxalyl chloride (2.00 M in CH2Cl2, 30.0 mL, 60.0 mmol, 1.2 eq.) and catalytic DMF (1.00 mL, 12.9 mmol, 
0.25 eq.) were sequentially added to an ice cooled solution of 2,3-dimethoxyphenylacetic acid[2] (7, 10.0 g, 
51.0 mmol, 1.0 eq.) in CH2Cl2 (150 mL). The reaction was stirred for 10 min at 0 °C and for 3 h at room 
temperature, before it was concentrated under reduced pressure. The resulting residue was redissolved in 
CH2Cl2 (100 mL) and added to a suspension of finely grinded AlCl3 (41.1 g, 308 mmol, 6 eq.) in CH2Cl2 
(720 mL) at –32 °C, that was previously purged with ethene. The reaction was stirred at –32 °C for 6 h 
under an ethene atmosphere before it was slowly quenched with H2O. The mixture was washed with H2O 
(400 mL), saturated aqueous NaHCO3 solution (400 mL) and saturated aqueous NaCl solution 400 mL). 
The organic phase was dried (MgSO4) and concentrated under reduced pressure. Purification of the 
resulting residue by flash column chromatography [PE/EA, 15:85] gave tetralone 6 (5.09 g, 24.7 mmol, 
48% over 2 steps) as a colorless solid. 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CHCl3] at 0 °C. 
Rf = 0.43 [PE/EtOAc, 3:1]. 
mp: 75 – 76 °C.  
 1H NMR (300 MHz, CDCl3): δ = 6.93 (d, J = 8.3 Hz, 1H), 6.79 (d, J = 8.3 Hz, 1H), 3.86 (s, 3H), 3.81 (s, 
3H), 3.60 (s, 2H), 3.05–2.96 (m, 2H), 2.59–2.49 (m, 2H) ppm. 
13C NMR (75 MHz, CDCl3): δ = 210.2, 151.0, 146.0, 129.3, 127.1, 122.6, 110.5, 60.2, 55.7, 38.5, 38.3, 
27.9 ppm. 
IR (ATR): ṽ = 2998 (w), 2944 (w), 2836 (w), 1702 (s), 1604 (w), 1582 (w), 1492 (s), 1458 (m), 1428 (m), 
1350 (m), 1307 (m) 1273 (s) cm‒1.  
HRMS (ESI): calcd. for C12H14O3+:   206.0937 [M+H]+  
found:       206.0942 [M+H]+. 
The analytical data matched those previously described in the literature.[3] 
 
1) (COCl)2, DMF
2) AlCl3, ethene, DCM
OMe
MeO
6
(48% over 2 steps)
O
OMe
MeO
COOH
7
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2-(7,8-Dimethoxy-2-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)acetonitrile (32) 
	  
To a solution of β-tetralone 6 (10.3 g, 44.2 mmol, 1.0 eq.) and a small amount of dry MgSO4 in toluene 
(260 mL) was added pyrrolidine (4.70 mL, 57.4 mmol, 1.3 eq.) and the reaction was stirred at 100 °C for 
24 h. The mixture was allowed to cool to room temperature, bromoacetonitrile (4.92 mL, 70.7 mmol, 
1.6 eq.) was added and the reaction was stirred at 100 °C for an additional 28 h. The reaction was 
quenched with H2O (300 mL) at room temperature, extracted with EtOAc (3 × 300 mL) and DCM 
(300 mL) and the combined organic layers were washed with saturated aqueous NaCl solution (400 mL), 
dried (MgSO4) and concentrated under reduced pressure. Flash column chromatography [PE/EtOAc, 9:1 
to 6:1] afforded 2-(7,8-dimethoxy-2-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)acetonitrile (32, 9.62 g, 
39.2 mmol, 89%) as colorless crystals. 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CHCl3] at 0 °C. 
Rf = 0.25 [PE/EtOAc, 3:1].  
mp: 77–79 °C. 
 1H NMR (300 MHz, CDCl3): δ = 6.94 (d, J = 8.3 Hz, 1H), 6.88 (d, J = 8.4 Hz, 1H), 3.90 (s, 3H), 3.88 (s, 
3H), 3.83 (dd, J = 4.5, 5.8 Hz, 1H), 3.34–3.15 (m, 2H), 2.95–2.89 (m, 2H, H-7b), 2.85–2.74 (m, 1H), 2.0 
(dddd, J = 15.2, 13.6, 6.1, 0.5 Hz, 1H) ppm.  
13C NMR (100 MHz, CDCl3) δ = 209.2, 150.8, 146.7, 129.7, 127.6, 123.2, 117.8, 112.3, 60.5, 55.7, 43.4, 
39.3, 27.1, 20.3 ppm. 
IR (ATR): ṽ = 3006 (w), 2974 (w), 2940 (w), 2918 (w), 2837 (w), 2244 (m), 1716 (s), 1606 (m), 1581 (m), 
1494 (s), 1456 (s), 1421 (s), 1347 (m), 1308 (m), 1279 (s), 1246 (m), 1220 (s), 1156 (m), 1091 (s), 999 
(s) cm‒1. 
HRMS (ESI): calcd. for C14H15O3N+:  245.1046 [M+H]+  
found:     245.1047 [M+H]+. 
 
326
MeO
OMe
O
MeO
OMe
O
pyrrolidine, toluene, MgSO4
 100 °C, 24 h
→ bromoacetonitrile, 100 °C, 28 h
NC(89%)
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Allyl (1-(cyanomethyl)-7,8-dimethoxy-3,4-dihydronaphthalen-2-yl) carbonate (31) 
	  
To a solution of nitrile 32 (10.5 g, 42.7 mmol, 1.0 eq.) in THF (800 mL) was added sodium hydride 
(60 wt% in mineral oil, 1.88 g, 47.0 mmol, 1.11 eq.) at 0 °C and the mixture was stirred at 0 °C for 1 h. 
Allyl chloroformate (4.54 mL, 42.7 mmol, 1.0 eq.) in THF (45.5 mL) was added and the reaction was 
stirred at 0 °C for an additional 30 min. The reaction was quenched with H2O (300 mL) at 0 °C, extracted 
with EtOAc (3 × 500 mL) and the combined organic layers were washed with saturated aqueous NaCl 
solution (500 mL), dried (MgSO4) and concentrated under reduced pressure. Flash column 
chromatography [pent/Et2O, 10:1 to 5:1] afforded carbonate 31 (13.8 g, 41.9 mmol, 98%) as a colorless 
oil. 
Rf = 0.41 [PE/EtOAc, 3:1].  
 1H NMR (400 MHz, CDCl3): δ = 6.85 (d, J = 8.2 Hz, 1H), 6.75 (d, J = 8.2 Hz, 1H), 5.98 (ddt, J = 17.1, 
10.4, 5.9 Hz, 1H), 5.43 (dq, J = 17.2, 1.5 Hz, 1H), 5.34 (dq, J = 10.4, 1.2 Hz, 1H), 4.75–4.71 (m, 2H), 3.90 
(s, 3H), 3.85 (s, 3H), 3.70 (s, 2H), 2.84–2.78 (m, 2H), 2.54–2.47 (m, 2H) ppm.  
13C NMR (101 MHz, CDCl3): δ = 151.7, 151.6, 151.1, 146.5, 130.6, 128.3, 125.3, 122.2, 119.5, 117.8, 
113.6, 111.2, 69.3, 61.3, 55.7, 28.4, 26.7, 16.4 ppm. 
IR (ATR): ṽ = 3319 (w), 3197 (w), 2942(m), 2836 (w), 22.51 (w), 1756 (s), 1661 (m), 1573 (w), 1477 (m), 
1418 (m), 1261 (s), 1241 (s), 1206 (s), 1183 (s), 980 (m) cm‒1. 
HRMS (ESI): calcd. for C18H19O5N+:   329.1258 [M+H]+  
found:     329.1255 [M+H]+. 
 
2-(1-Allyl-7,8-dimethoxy-2-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)acetonitrile (8) 
	  
NaH, THF, 0 °C, 1 h → allyl 
chloroformate, 0 °C, 30 min
3132
MeO
OMe
O
MeO
OMe
O
NC
NC
O O
(98%)
Pd2(dba)3, PPh3
toluene, r.t., 16 h
8
OMe
MeO
O
NC
(84%)
31
MeO
OMe
O
NC
O O
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Tris(dibenzylideneacetone)dipalladium(0) (677 mg, 0.740 mmol, 2.5 mol%) and PPh3 (485 mg, 1.85 mmol, 
6.25 mol%) were dissolved in degassed toluene (700 mL) and stirred until the reaction color turned from 
dark red to orange/yellow (approximately 30 min.). A solution of carbonate 31 (9.75 g, 29.6 mmol, 1.0 eq.) 
in degassed toluene (100 mL) was added to the preformed catalyst and the reaction was stirred at room 
temperature for 16 h prior to concentrating the reaction mixture under reduced pressure. Flash column 
chromatography [PE/EtOAc, 9:1] afforded 2-(1-allyl-7,8-dimethoxy-2-oxo-1,2,3,4-tetrahydronaphthalen-
1-yl)acetonitrile (8, 7.11 g, 24.9 mmol, 84%) as a colorless solid. 
Note: The yields for this transformation were significantly higher on smaller scale (e.g.: 97% on 17.7 mmol scale). 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CHCl3] at 20 °C. 
Rf = 0.41 [PE/EtOAc, 3:1]. 
mp: 70–71 °C. 
1H NMR (600 MHz, CDCl3): δ = 6.92–6.85 (m, 2H), 5.39 (dddd, J = 17.0, 10.1, 9.0, 5.9 Hz, 1H), 5.00–
4.94 (m, 2H), 3.97 (s, 3H), 3.88 (s, 3H), 3.29 (d, J = 16.4 Hz, 1H), 3.13 (d, J = 16.3 Hz, 1H), 3.05 (dddd, 
J = 15.8, 9.7, 6.0, 0.6 Hz, 1H), 3.01–2.94 (m, 1H), 2.90 (ddt, J = 13.7, 5.8, 1.5 Hz, 1H), 2.76–2.64 (m, 2H), 
2.71 (m, 1H) ppm.  
13C NMR (150 MHz, CDCl3): δ = 210.4, 151.3, 147.7, 132.5, 129.8, 129.2, 123.4, 118.9, 117.8, 112.5, 60.4, 
55.6, 53.8, 42.6, 39.0, 28.2, 24.6 ppm. 
IR (ATR): ṽ = 2941 (m), 2839 (w), 1715 (s), 1601 (w), 1576 (w), 1486 (s), 1454 (m), 1415 (w), 1346 (w), 
1275 (s) cm‒1. 
HRMS (ESI): calcd. for C17H20O3N+:   286.1438 [M+H]+  
found:     286.1435 [M+H]+. 
 
Methyl-4-(1-(cyanomethyl)-7,8-dimethoxy-2-oxo-1,2,3,4-tetra-hydronaphthalen-1-yl)but-2-enoate 
(5) 
 
To a solution of α-allylcyclohexanone 8 (7.11 g, 24.9 mmol, 1.0 eq.) and methyl acrylate (33.9 mL, 
37.4 mmol, 15 eq.) in toluene (320 mL) was added Hoveyda−Grubbs catalyst 2nd generation (780 mg, 
OMe
MeO
O
NC
OMe
MeO
O
NC
O
OMe
methyl acrylate
HG II, toluene, r.t, 48 h
8 5
(97%)
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1.25 mmol, 5 mol%) and the reaction was stirred for 48 h at room temperature prior to concentrating the 
reaction mixture under reduced pressure. Flash column chromatography [PE/EtOAc, 9:1 to 2:1] afforded 
conjugated ester 5 (8.29 g, 24.2 mmol, 97%) as a colorless solid. 
E/Z -ratio: 27:1 (determined by integrals of H-13 in 1H NMR). 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [PE/EtOAc, 15:1] at 
0 °C. 
Rf = 0.24 [PE/EtOAc, 3:1].  
mp: 78–81 °C. 
1H NMR (600 MHz, CDCl3) of the E-isomer: δ = 6.93–6.87 (m, 2H), 6.46 (ddd, J = 15.5, 9.3, 6.2 Hz, 
1H), 5.72 (ddd, J = 15.5, 1.6, 1.0 Hz, 1H), 3.96 (s, 3H), 3.88 (s, 3H), 3.65 (s, 3H), 3.32 (d, J = 16.4 Hz, 
1H), 3.09 (d, J = 16.4 Hz, 1H), 3.07–3.01 (m, 2H), 2.92 (ddd, J = 15.8, 7.4, 5.5 Hz, 1H), 2.82 (ddd, J = 0.9, 
9.3, 13.8 Hz, 1H), 2.73 (ddd, J = 13.7, 7.6, 5.2 Hz, 1H), 2.63 (ddd, J = 13.9, 9.6, 5.5 Hz, 1H) ppm. 
13C NMR (150 MHz, CDCl3) of the E-isomer: δ = 210.4, 166.2, 151.7, 147.9, 142.7, 130.0, 128.4, 124.7, 
124.0, 117.6, 113.2, 60.8, 56.0, 53.6, 51.7, 40.7, 39.3, 28.3, 25.7 ppm. 
IR (ATR): ṽ = 2948 (w), 1719 (s), 1657 (w), 1488 (m), 1438 (m), 1438 (w), 1347 (w), 1277 (s), 1214 (w), 
1171 (m), 1111 (w), 1027 (w), 982 (w), 807 (w) cm‒1.  
HRMS (EI): calcd. for C19H25N2O5+:  361.1758 [M+NH4]+ 
found:    361.1760 [M+NH4]+. 
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Screening for reductive aldol conditions 
Table S1 Conditions tested for the reductive aldol reaction of ester 5. 
	
Entry Condit ionsa)  Observation  
1 [PPh3CuH]6 (1.5 eq.), toluene,  −40 °C, 4 h →  sat. NH4Cl mixture of 9, 10, 11 
2 [PPh3CuH]6 (1.5 eq.), toluene,  −40 °C, 4 h →  sat. NH4Cl mixture of 9, 10, 11 
3 [PPh3CuH]6 (0.5 eq.), toluene, −78 °C to −40 °C, 10 h → sat. NH4Cl	 >50% 10 
4 [PPh3CuH]6 (0.5 eq.), toluene, 0 °C, 4 h →  sat. NH4Cl 38% 9b) 
5 [PPh3CuH]6 (0.5 eq.), toluene, r.t., 4 h → sat. NH4Cl 41% 9b) 
6 [PPh3CuH]6 (0.33 eq.), toluene, r.t., 18 h → sat. NH4Cl 34% 9b) 
7 [PPh3CuH]6 (0.5 eq.), toluene, r.t., 4 h → 1 M HCl + TMEDA 60% 9b) 
8 [PPh3CuH]6 (0.5 eq.), toluene, r.t., 4 h → citric acid + TMEDA 47% 9b) 
9 Cu(OAc)2 (0.5 eq.), TMDS, dppf, THF, r.t. 24 h → 1 M HCl + TMEDA 30% 9b) 
10 Cu(OAc)2 (0.1 eq.), TMDS, rac-BINAP, THF, r.t. 24 h → 1 M HCl + TMEDA 63% 5 and 37% 9b) 
11 Cu(OAc)2 (0.5 eq.), TMDS, rac-BINAP, THF, r.t. 24 h → 1 M HCl + TMEDA 60% 9b) 
12 Cu(OAc)2 (1 eq.), TMDS, rac-BINAP, THF, r.t. 24 h → NaH, 0 °C, 2 h complex mixture 
13 L-selectride (1.6 eq.), THF, −78 °C, 1 h → sat. NH4Cl decomposition 
14 Rh(cod)2OTf, PPh3, H2, K2CO3, DCE starting material 
a) All solvents were degassed using standard freeze-pump-thaw techniques (minimum of three cycles) 
b) Material was accompanied by decomposed starting material and 11 as the major by-product 
 
General Procedure for the Synthesis of Methyl 8,9-dimethoxy-11-oxo-2,3,4,5-tetrahydro-1H-3a,9b-
(epoxyethano)-cyclopenta-[a]naphtha-lene-3-carboxylate (9) 
 
A solution of Cu(OAc)2·H2O (28.9 mg, 146 µmol, 0.5 eq.) and rac-BINAP (90.0 mg, 146 µmol, 0.5 eq.) in 
deg. THF (3 mL) was stirred for 15 min. before TMDS (39.1 mg, 291 µmol, 1 eq.) was added. After 
conditions
10
OMe
MeO
O
NC
O
OMe
5
OMe
MeO
O
NC
O
OMe
11 9
O
OMe
MeO
O
H
O OMe
or
HO
OMe
MeO
H
O OMe
N
OMe
MeO
O
NC
O
OMe
5
O
OMe
MeO
O
H
O OMe
(60%)
Cu(OAc)2z+2, rac-BINAP
TMDS, THF, r.t., 24 h
→ 1 M HCl, r.t., 1 h
9
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additional 15 min. a solution of unsaturated ester 5 (100 mg, 291 µmol, 1 eq.) in deg. THF (1 mL + 
0.5 mL rinse) was added rapidly and the reaction stirred for 24 h at room temperature. The reaction was 
quenched by the addition of aqueous 1 M HCl (2 mL) and the mixture stirred for 1 h before it was diluted 
with aqueous saturated NH4Cl (20 mL) and TMEDA (0.1 mL). The mixture was extracted with EtOAc 
(3 × 20 mL) and the combined organic layers were washed with saturated aqueous NaCl solution (40 mL), 
dried (MgSO4) and concentrated under reduced pressure. Flash column chromatography [pent/Et2O, 3:1] 
afforded teracyclic lactone 9 (60.6 mg, 176 µmol, 60%) as colorless crystals. 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [PE/EtOAc, 20:1] at 
0 °C. 
Rf = 0.24 [PE/EtOAc, 3:1].  
1H NMR (400 MHz, CDCl3) δ = 6.86–6.76 (m, 2H), 3.89 (s, 3H), 3.85 (s, 3H), 3.77 (s, 3H), 3.21 (d, 
J = 18.7 Hz, 1H), 2.94 (dd, J = 6.8, 11.4 Hz, 1H), 2.86–2.77 (m, 2H), 2.72 (dd, J = 10.0, 21.8 Hz, 1H), 2.60 
(dd, J = 4.4, 13.4 Hz, 1H), 2.52 (ddd, J = 13.7, 7.5, 1.8 Hz, 1H), 2.30–2.14 (m, 1H), 2.01–1.87 (m, 2H), 
1.82 (dddd, J = 13.2, 12.1, 7.3, 0.8 Hz, 1H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 175.9, 170.8, 151.6, 147.2, 136.2, 127.1, 123.4, 111.7, 95.3, 60.7, 56.0, 
52.2, 50.7, 50.4, 44.3, 40.5, 30.6, 26.1, 25.5 ppm. 
IR (ATR): ṽ = 2927 (m), 2850 (w), 1772 (s), 1735 (s), 1603 (w), 1489 (s), 1455 (m), 1418 (w), 1355 (w), 
1279 (s), 1207 (m), 1192 (m), 1062 (s), 1026 (m) cm-1. 
HRMS (EI): calcd. for C20H27NO5+:   346.1651 [M+H]+  
found:    346.1649 [M+H]+.  
 
Methyl 4-(1-(cyanomethyl)-7,8-dimethoxy-2-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)-butaneate (11) 
 
To a solution of crude  α,β-unsaturated ester 5 (8.29 g, 24.2 mmol, 1.0 eq.) in EtOAc (500 mL), Pd/C 
(10 wt%, 829 mg) was added. The flask was purged with H2 five times and stirred under H2 atmosphere 
(1 atm) at room temperature for 12 h. The catalyst was removed by filtration through a pad of silica, 
which was washed with EtOAc (500 mL) to afforded saturated ester 11 (8.10 g, 23.5 mmol, 97%) as a 
colorless solid. 
OMe
MeO
O
NC
O
OMe
11
(97%)
OMe
MeO
O
NC
O
OMe
5
Pd/C, H2 (1 bar)
EtOAc, r.t., 12 h
 S12 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CHCl3] at 20 °C. 
Rf = 0.24 [PE/EtOAc, 3:1]. 
mp: 85–88 °C. 
1H NMR (400 MHz, CDCl3): δ = 6.97–6.79 (m, 2H), 3.92 (s, 3H), 3.85 (s, 3H), 3.58 (s, 3H), 3.31 (d, 
J = 16.4 Hz, 1H), 3.16–2.91 (m, 3H), 2.75 (t, J = 7.0 Hz, 2H), 2.17 (dt, J = 7.9, 6.6 Hz, 2H), 2.05 (dt, 
J = 11.0, 4.9 Hz, 2H), 1.43–1.25 (m, 1H), 1.28–1.12 (m, 1H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 211.5, 173.3, 151.7, 148.0, 130.0, 129.7, 123.8, 118.1, 112.7, 60.7, 55.9, 
53.9, 51.7, 39.4, 37.8, 34.0, 28.6, 25.8, 20.9 ppm. 
IR (ATR): ṽ = 2948 (m), 2842 (w), 1733 (s), 1712 (s), 1601 (w), 1577 (w), 1486 (s), 1453 (m), 1438 (m), 
1415 (m), 1345 (m), 1275 (s), 1232 (m), 1210 (m), 1169 (s), 1106 (s), 1049 (s), 1012 (m), 982 (m) cm‒1. 
HRMS (EI): calcd. for C19H24NO5+:   346.1649 [M+H]+  
found:    346.1651 [M+H]+.  
 
Screening for cascade reaction 
Table S2 Conditions tested for the aldol reaction of 11. 
	
Entry 
Scale 
[mmol] Condit ions  11 : 10 : 16+17a) d.r.  of 16 : 17 
1 0.3 NaOMe (0.25 eq.), MeOH, 20 °C to 70 °C, 12 h 1 : 2 : 0 − 
2 0.3 NaOMe (1.2 eq.), MeOH, 75 °C, 26 h 0 : 0 : >99 4:1 
3 0.3 Na (1.2 eq.), MeOH, 75 °C, 26 h 0 : 0 : >99 9:1 
4 3.2 Na (1.2 eq), 3 Å MS, MeOH, 75 °C, 16 h 0 : 0 : >99 10:1 
5 24.4 Na (1.2 eq), 3 Å MS, MeOH, 75 °C, 16 h 0 : 0 : 91 10:1 
a) Ratio was determined by comparison of the methoxy signals in the 1H NMR spectrum of the crude reaction mixture. 
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General Procedure for the Synthesis of Methyl 8,9-dimethoxy-11-oxo-2,3,4,5-tetrahydro-1H-3a,9b-
(epiminoethano)-cyclopenta-[a]naph-thalene-3-carboxylate (16 and 17) 
 
Sodium (561.0 mg, 24.4 mmol, 1.3 eq.) was dissolved in MeOH (450 mL) containing a small amount of 
molecular sieves (3 Å). A solution of saturated ester 11 (6.47 g, 18.7 mmol, 1.0 eq.) in MeOH (50 mL) was 
added and the mixture was heated to 75 °C for 16 h. Aqueous saturated NH4Cl solution (100 mL) and 
H2O (150 mL) were added and the aqueous layer was extracted with EtOAc (3 × 700 mL). The combined 
organic layers were washed with saturated aqueous NaCl solution (1000 mL), dried (MgSO4) and 
concentrated under reduced pressure. Flash column chromatography [PE/EtOAc, 2:1 to 0:1] afforded 
lactams 16 and 17 (5.87 g, 17.0 mmol, 91%) as a colorless solid with a d.r. of 10:1.  
Note: The yield for this transformation was 99% on smaller scale (e.g.: 3.21 mmol). 
Both diastereomers were separated and crystals suitable for single-crystal X-ray analysis were obtained 
from recrystallization [i-Hex/EtOAc, 20:1] at 0 °C. 
Full characterization of the major diastereomer (16):  
Rf = 0.41 [EtOAc].  
m.p.: 160–162 °C (decomposition). 
1H NMR (400 MHz, CDCl3) δ = 6.81–6.71 (m, 2H), 6.47 (s, 1H), 3.86 (s, 3H), 3.82 (s, 3H), 3.71 (s, 3H), 
2.98 (d, J = 17.7 Hz, 1H), 2.87 (dd, J = 11.8, 6.4 Hz, 1H), 2.74 (dt, J = 16.5, 4.8 Hz, 1H), 2.67 (dd, 
J = 11.8, 4.3 Hz, 1H), 2.58 (d, J = 17.7 Hz, 1H), 2.49 (dd, J = 12.7, 7.4 Hz, 1H), 2.21 (dt, J = 13.6, 4.4 Hz, 
1H), 2.05 (td, J = 11.2, 10.5, 6.8 Hz, 1H), 2.12–1.82 (m, 3H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 175.8, 173.3, 151.5, 147.2, 137.6, 126.7, 123.2, 111.1, 69.2, 60.5, 55.8, 
52.0, 49.6, 49.3, 46.5, 41.9, 31.6, 26.9, 26.0 ppm. 
IR (ATR): ṽ = 3185 (w), 2952 (m), 2363 (w), 2334 (w), 1734 (m), 1693 (s), 1488 (m), 1416 (m), 1351 (w), 
1279 (m), 1214 (m), 1098 (m), 1059 (w), 1023 (w), 984 (w), 797 (w) cm-1. 
HRMS (EI): calcd. for C19H23NO5+:   345.1576 [M+H]+  
found:    345.1581 [M+H]+. 
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Characterization of the minor diastereomer (17):  
Rf = 0.39 [EtOAc]. 
1H NMR (400 MHz, CDCl3) δ = 6.80–6.72 (m, 2H), 6.04 (s, 1H), 3.92 (s, 3H), 3.84 (s, 3H), 3.75 (s, 3H), 
3.13 (dd, J = 11.1, 8.4 Hz, 1H), 2.93 (d, J = 18.1 Hz, 1H), 2.86–2.71 (m, 2H), 2.58 (dt, J = 16.1, 4.3 Hz, 
1H), 2.46 (dt, J = 14.0, 9.2 Hz, 1H), 2.21–2.10 (m, 1H), 2.10–1.95 (m, 2H), 1.76 (dd, J = 8.4, 4.3 Hz, 
2H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 176.5, 172.8, 151.5, 147.4, 136.3, 127.6, 122.9, 111.7, 69.8, 60.7, 56.1, 
55.8, 52.0, 50.8, 48.2, 39.2, 26.3, 25.8, 24.6 ppm. 
IR (ATR): ṽ = 3210 (w), 2945 (w), 1732 (m), 1693 (s), 1489 (m), 1453 (m), 1437 (w), 1415 (w), 1361 (w), 
1280 (m), 1217 (m), 1171 (w), 1102 (w), 1072 (w), 1031 (w), 988 (w), 801 (w), 760 (w) cm-1. 
HRMS (EI): calcd. for C19H23NO5+:   345.1576 [M]+  
found:    345.1571 [M]+. 
 
Methyl 8,9-dimethoxy-12-methyl-11-oxo-2,3,4,5-tetrahydro-1H-3a,9b-(epimi-noethano)-cyclopen-
ta[a]naphthalene-3-carboxylate (S1) 
	  
A mixture of amides 16 and 17 (5.87 g, 17.0 mmol, 1.0 eq.) was dissolved in DMF (600 mL) and NaH 
(60 wt% in mineral oil, 784 mg, 19.6 mmol, 1.15 eq.) was added to the stirring solution at 0 °C. The 
reaction mixture was kept at 0 °C and MeI (1.22 mL, 19.6 mmol, 1.15 eq.) was added slowly. The reaction 
was heated to 30 °C and after 14 h it was stopped by the addition of saturated aqueous NH4Cl solution 
(50 mL). A solution of 10% LiCl in H2O (1000 mL) was added and the aqueous layer was extracted with 
EtOAc (3 × 750 mL). The combined organic layers were washed with saturated aqueous NaCl solution 
(1000 mL), dried (MgSO4) and concentrated under reduced pressure. Flash column chromatography 
[PE/EtOAc, 1:1 to 2:1] afforded N-methyl amide S1 (5.57 g, 15.5 mmol, 91%) as a bright yellow solid. 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CHCl3] at 0 °C. 
Full characterization of the major diastereomer (S1):  
MeI, NaH, DMF 
30 °C, 14 h
(91%) N
OMe
MeO
O
H
O OMe
S1
N
OMe
MeO
H
O OMe
H
O
16 + 17
 S15 
Rf = 0.25 [EtOAc/PE, 2:1]. 
1H NMR (400 MHz, CDCl3) δ = 6.76 (s, 2H, H-4, H-5), 3.89 (s, 3H), 3.84 (s, 3H), 3.73 (s, 3H), 3.05 (d, 
J = 17.7 Hz, 1H), 2.80 (dd, J = 11.2, 6.7 Hz, 1H), 2.70 (s, 3H), 2.55 (m, 2H), 2.55 (d, J = 17.7 Hz, 1H), 
2.30 (ddd, J = 13.6, 7.7, 4.4 Hz, 1H), 2.20 – 2.07 (m, 1H), 2.00 (td, J = 8.6, 4.1 Hz, 1H), 1.95 – 1.87 (m, 
1H), 1.81 (ddd, J = 13.6, 11.6, 7.4 Hz, 1H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 175.0, 172.9, 151.6, 147.6, 137.3, 127.3, 123.2, 111.3, 75.0, 60.7, 56.0, 
52.1, 51.1, 49.3, 46.0, 39.6, 29.7, 26.1, 26.0 ppm. 
IR (ATR): ṽ = 2949 (bm), 1733 (m), 1688 (s), 1487 (m), 1452 (w), 1417 (w), 1389 (w), 1279 (m), 1211 (w), 
1169 (w), 1099 (1), 1062 (m), 981 (w), 803 (w) cm-1. 
HRMS (EI): calcd. for C20H25NO5+:   359.1727 [M]+  
found:    359.1719 [M]+. 
 
8,9-Dimethoxy-12-methyl-11-oxo-2,3,4,5-tetrahydro-1H-3a,9b-(epiminoethano)cyclopenta[a]naph-
thalene-3-carbaldehyde (18) 
		  
A solution of methylated lactam S1 (1.00 g, 2.78 mmol, 1.0 eq.) in dry DCM (200 mL) was cooled 
to -78 °C. After 15 min. DIBAL-H (1.0 M solution in DCM, 3.48 mL, 3.48 mmol, 2.5 eq.) was added and 
the reaction mixture was stirred at –78 °C for 3.5 h. Then, the reaction was quenched with EtOAc 
(50 mL) and stirred for another 15 min at –78 °C. Aqueous 10% NaOH solution (50 mL) was added and 
the mixture was allowed to warm up to room temperature. Aqueous 10% NaOH solution (200 mL) was 
added, the aqueous layer was extracted with EtOAc (3 × 500 mL) and the combined organic layers were 
washed with aqueous saturated NaCl solution (1000 mL), dried (MgSO4) and concentrated under reduced 
pressure. Flash column chromatography on DAVISIL® [DCM/acetone, 1:0 to 1:1] afforded aldehyde 18 
(725 mg, 2.20 mmol, 79%) as a yellow oil. 
d.r .= 1:1.3. 
Rf = 0.28 [DCM/MeOH, 10:1]. 
1H NMR (400 MHz, CDCl3): δ = 9.86 (d, J = 2.6 Hz, 1H), 9.78 (d, J = 3.5 Hz, 1H), 6.79–6.74 (m, 4H), 
3.91 (s, 5H), 3.91 (s, 3H), 3.84 (s, 7H), 3.01 (t, J = 18.0 Hz, 2H), 2.92 (s, 3H), 2.85 (td, J = 8.5, 2.7 Hz, 
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1H), 2.74 (s, 3H), 2.71–2.58 (m, 5H), 2.58–2.35 (m, 4H), 2.25–2.09 (m, 3H), 2.09–1.87 (m, 6H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 202.6, 202.1, 174.7, 173.4, 151.7, 151.6, 147.5, 147.5, 136.6, 135.7, 
127.9, 127.2, 123.2, 123.0, 111.5, 111.5, 75.8, 75.6, 60.7, 60.7, 60.1, 59.2, 56.0, 49.8, 49.6, 46.0, 45.7, 39.8, 
38.9, 30.2, 27.5, 26.6, 25.9, 25.6, 25.5, 25.3, 25.1 ppm. 
IR (ATR): v ̃ = 3854 (w), 2938 (m), 2838 (w). 2731 (w), 1714 (m), 1685 (s), 1602 (w), 1576 (w), 1488 (s), 
1453 (m), 1471 (m), 1392 (m), 1355 (w), 1277 (s), 1250 (w), 1208 (w), 1100 (w), 1058 (m), 982 (w), 934 (w), 
800 (w), 748 (w), 665 (w) cm-1.  
HRMS (ESI): calculated for C19H24NO4+ : 330.1700 [M+H]+ 
  found:     330.1699 [M+H]+. 
 
3,3-Bis(hydroxymethyl)-8,9-dimethoxy-12-methyl-2,3,4,5-tetrahydro-1H-3a,9b-(epiminoethano)-
cyclopenta[a]naphthalene-11-one (19) 
	  
To a solution of aldehyde 18 (793 mg, 2.41 mmol, 1 eq.) in MeOH (40 mL) was added KOH (1.35 g, 
24.1 mml, 10 eq.) dissolved in MeOH (40 mL) followed by formaldehyde (37% in H2O, 1.81 mL, 
333 µmol, 10 eq.). The reaction mixture stirred 50 °C for 72 h. Then, the mixture was diluted with H2O 
(300 mL). The aqueous layer was extracted with EtOAc (3 × 200 mL) and DCM (200 mL) and the 
combined organic layers were washed with aqueous saturated NaCl solution (500 mL), dried (Na2SO4) and 
concentrated under reduced pressure. Flash column chromatography [DCM/acetone, 1:0 to 1:2] afforded 
diol 19 (356 mg, 985 µmol, 41%) as a colorless solid.  
Note: The yields for this transformation were significantly higher on smaller scale (e.g.: 73% on 33.3 µmol scale). 
Rf = 0.21 [CHCl3/acetone, 1:1]  
1H NMR (400 MHz, CDCl3): δ = 6.76–6.69 (m, 2H), 3.91 (s, 3H), 3.82 (s, 3H), 3.80–3.60 (m, 4H), 2.98–
2.94 (m, 1H), 2.93 (s, 3H), 2.62–2.57 (m, 1H), 2.57–2.54 (m, 1H), 2.53–2.47 (m, 1H), 2.47–2.40 (m, 1H), 
2.39–2.33 (m, 1H), 2.11 (ddd, J = 14.3, 9.2, 4.2 Hz, 1H), 1.81 (ddd, J = 17.6, 8.5, 4.3 Hz, 1H), 1.72 (dd, 
J = 13.7, 3.9 Hz, 1H), 1.52–1.39 (m, 1H) ppm.  
13C NMR (101 MHz, CDCl3) δ = 175.9, 151.6, 147.3, 138.4, 128.0, 122.5, 111.5, 76.8, 64.2, 60.6, 56.1, 
55.4, 50.7, 50.4, 38.2, 30.5, 27.7, 25.5, 24.7 ppm. 
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IR (ATR): ṽ = 3396 (m), 2941 (m), 2361 (m), 2341 (m), 1654 (vs), 1489 (s), 1456 (m), 1400 (m), 1278 (s), 
1086 (m), 1063 (m), 986 (w) cm-1. 
HRMS (ESI): calculated for C20H28NO5+:  362.19620 [M+H]+ 
    found:    362.19633 [M+H]+. 
 
4-(Hydroxymethyl)-10,11-dimethoxy-3-methyl-4,5-dihydro-1H ,7H-4,11b-ethano-3a,7-methano-
benzo[6,7]oxocino[4,5-b]pyrrol-2(3H)-one (20) 
 
Diol 19 (560 mg, 1.55 mmol, 1.0 eq.) was suspended in dichloroethane (56 mL). DDQ (3.52 g, 15.5 mmol, 
10 eq.), concentrated AcOH (890 µL, 15.5 mmol, 10 eq.) and 4Å molecular sieves were added to the 
suspension and the reaction mixture was stirred at 75 °C for 5 h. The reaction mixture was allowed to cool 
to room temperature and DCM (200 mL) were added. The organic phase was washed with 10% aqueous 
NaOH solution (2 × 200 mL), aqueous saturated NaHCO3 solution (2 × 200 mL) and aqueous saturated 
NaCl solution (200 mL), dried (MgSO4) and concentrated under reduced pressure. Flash column 
chromatography [DCM/acetone, 2:1 to 0:1] afforded cyclic ether 20 (511 mg, 1.42 mmol, 92%) as a white 
solid. 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CHCl3] at 0 °C. 
Rf = 0.36 [CHCl3/acetone, 1:1]. 
1H NMR (400 MHz, CDCl3): δ = 6.95 (d, J = 8.3 Hz, 1H), 6.86 (d, J = 8.4 Hz, 1H), 4.98 (dd, J = 4.3, 
1.7 Hz, 1H), 4.09–3.99 (m, 1H), 3.92 (s, 3H), 3.88 (s, 3H), 3.86 – 3.77 (m, 1H), 3.69–3.63 (m, 1H), 3.46–
3.40 (m, 1H), 3.23 (d, J = 17.3 Hz, 1H), 3.08 (s, 3H), 3.04–2.95 (m, 1H), 2.49–2.43 (m, 1H), 2.35–2.25 (m, 
2H), 1.60–1.51 (m, 1H), 1.50–1.47 (m, 1H), 1.23–1.14 (m, 1H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 176.4, 153.7, 146.0, 140.8, 124.8, 124.7, 111.3, 73.2, 73.0, 69.4, 67.1, 
60.7, 55.9, 51.2, 49.3, 45.6, 40.9, 30.6, 30.3, 29.1 ppm. 
IR (ATR): ṽ = 3421 (m), 2943 (m), 2360 (w), 2340 (w), 1734 (w), 1671 (vs), 1602 (w), 1576 (w), 1559 (w), 
1541 (w), 1487 (s), 1456 (m), 1421 (m), 1394 (m), 1355 (m), 1313 (m), 1275 (s), 1229 (m), 1176 (w), 1130 
(w), 1103 (m), 1086 (m), 1068 (m), 1040 (m), 983 (m), 960 (w), 931 (w), 814 (w), 749 (w), 668 (w) cm-1.  
HRMS (ESI): calculated for C20H26NO5+:   360.1805 [M+H]+ 
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found:      360.1805 [M+H]+. 
 
10,11-Dimethoxy-3-methyl-2-oxo-2,3-dihydro-1H ,7H-4,11b-ethano-3a,7-methanobenzo[6,7]oxo-
cino[4,5-b]pyrrole-4(5H)-carbaldehyde (S2) 
 
To a solution of primary alcohol 20 (214 mg, 0.603 mmol, 1.0 eq.) in DCM (20 mL) was added 4 Å MS 
followed by NMO (706 mg, 6.03 mmol, 10 eq.) and TPAP (10.6 mg, 30.2 µmol, 0.05 eq.). The reaction 
mixture was stirred at room temperature for 1 h. The oxidant was removed by filtration through a pad of 
silica that was washed with DCM/acetone (1:1, 10 mL) to afford aldehyde S2 (201 mg, 0.563 mmol, 93%) 
as a colorless solid. 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CDCl3] at room 
temperature. 
Rf = 0.79 [DCM/acetone, 2:1].   
1H NMR (400 MHz, CDCl3) δ = 10.20 (s, 1H), 6.92 (d, J = 8.3 Hz, 1H), 6.82 (d, J = 8.3 Hz, 1H), 5.02 
(dd, J = 4.1, 1.9 Hz, 1H), 3.87 (s, 3H), 3.82 (s, 3H), 3.54 (d, J = 13.1 Hz, 1H), 3.32 (d, J = 13.1 Hz, 1H), 
3.17 (d, J = 17.2 Hz, 1H), 2.84 (dd, J = 12.9, 4.0 Hz, 1H), 2.67 (s, 3H), 2.39 (d, J = 17.2 Hz, 1H), 2.36–
2.20 (m, 2H), 2.15–2.03 (m, 1H), 1.63–1.55 (m, 1H), 1.37–1.28 (m, 1H) ppm.  
13C NMR (101 MHz, CDCl3): δ = 202.9, 174.5, 153.8, 146.0, 139.5, 125.0, 124.3, 111.7, 72.8, 72.6, 62.9, 
60.8, 60.7, 55.9, 49.1, 44.8, 40.2, 29.4, 27.7, 27.4 ppm. 
IR (ATR): ṽ = 2943 (m), 2360 (w), 2339 (w), 1716 (s), 1684 (s), 1601 (w), 1576 (w), 1559 (w), 1540 (w), 
1488 (m), 1456 (m), 1421 (w), 1394 (w), 1356 (w), 1311 (w), 1275 (s), 1230 (w), 1126 (w), 1102 (w), 1083 
(m), 1067 (m), 1048 (w), 1030 (w), 986 (w), 951 (w), 913 (w), 813 (m), 750 (w), 668 (m) cm‒1.  
HRMS (EI): calcd. for C20H24NO5+:  358.1649 [M+H]+ 
found:    358.1648 [M+H]+. 
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10,11-Dimethoxy-3-methyl-2-oxo-2,3-dihydro-1H ,7H-4,11b-ethano-3a,7-methanobenzo[6,7]oxo-
cino[4,5-b]pyrrole-4(5H)-carboxylic acid (S3) 
 
To a solution of aldehyde S2 (231 mg, 0.647 mmol, 1.0 eq.) and 2-methyl-2-butene (2.4 mL) in t-BuOH 
(10.2 mL) was added a solution of NaClO2 (80% purity, 544 mg, 4.81 mmol, 7.4 eq.) and NaH2PO4 
(75.2 g, 4.81 mmol, 7.4 eq.) in H2O (9.14 mL). After 3 h, the reaction mixture was diluted with an aqueous 
10% NaOH solution (20 mL) and the aqueous phase was extracted with hexanes (50 mL). The aqueous 
phase was acidified with aqueous 1 M HCl solution (to pH = 1) and extracted with DCM (3 × 100 mL). 
The combined DCM layers were dried (Na2SO4) and concentrated under reduced pressure to give 
carboxylic acid S3 (231.5 mg, 0.620 mmol, 96%) as a colorless solid. 
Rf = 0.51 [acetone/DCM 1:3 + 1% AcOH]. 
1H NMR (400 MHz, CDCl3) δ = 6.90 (d, J = 8.3 Hz, 1H), 6.80 (d, J = 8.3 Hz, 1H), 5.00 (dd, J = 4.2, 1.7 Hz, 
1H), 3.86 (s, 3H), 3.82 (s, 3H), 3.58 (d, J = 13.0 Hz, 1H), 3.35 (d, J = 13.0 Hz, 1H), 3.23–3.07 (m, 2H), 2.80 (s, 3H), 
2.40 (d, J = 17.2 Hz, 1H), 2.36–2.17 (m, 3H), 1.56–1.39 (m, 3H) ppm. 
13C NMR (150 MHz, CDCl3): δ = 176.9, 175.0, 153.6, 145.8, 139.6, 124.7, 124.3, 111.6, 77.4, 72.7, 72.1, 
64.1, 60.6, 55.8, 54.6, 48.7, 44.8, 39.7, 28.4, 26.1 ppm. 
IR (ATR): ṽ = 3267 (w), 2946 (m), 1758 (s), 1674 (m), 1596 (w), 1490 (m), 1455 (m), 1423 (w), 1390 (m), 
1277 (s), 1217 (m), 1147 (w), 1090 (m), 1048 (m), 820 (w), 762 (w) cm‒1.  
HRMS (EI): calcd. for C20H22NO6-:  372.1453 [M−H]− 
found:    372.1456 [M−H]-. 
 
Benzyl-10,11-dimethoxy-3-methyl-2-oxo-2,3-dihydro-1H ,7H-4,11b-ethano-3a,7-methano-
benzo[6,7]oxocino[4,5-b]pyrrol-4(5H)-yl)carbamate (21) 
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Carboxylic acid S3 (232 mg, 0.620 mmol, 1.0 eq.) was dissolved in toluene (15 mL) and 
diphenylphosphoryl azide (200 µL, 0.930 mmol, 1.5 eq.) and NEt3 (260 µL, 1.86 mmol, 3 eq.) were added. 
The reaction was stirred at room temperature for 1 h and then heated to 100 °C for another 1 h. After 
cooling to room temperature, benzyl alcohol (310 µL, 3.1 mmol, 5 eq.) was added and the reaction was 
heated to 100 °C for additional 14 h. The reaction mixture was diluted with H2O (100 mL) and extracted 
with DCM (3 × 100 mL). The combined organic layers were washed with saturated aqueous NaCl 
solution (200 mL), dried (MgSO4) and concentrated under reduced pressure. Flash column 
chromatography [PE/EtOAc, 1:1 to 0:1] afforded Cbz-protected amine 21 (250 mg, 0.523 mmol, 84%) as 
a colorless solid. 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CHCl3] at 20 °C. 
Rf = 0.76 [DCM/acetone, 1:1].  
1H NMR (600 MHz, CDCl3) δ = 7.41–7.30 (m, 5H), 6.94 (d, J = 8.3 Hz, 1H), 6.86 (d, J = 8.3 Hz, 1H), 
5.52 (s, 1H), 5.07 (d, J = 3.0 Hz, 2H), 4.97–4.89 (m, 1H), 3.92 (s, 3H), 3.87 (s, 3H), 3.64 (d, J = 12.9 Hz, 
1H), 3.34 (d, J = 12.9 Hz, 1H), 3.22 (d, J = 17.2 Hz, 1H), 2.94 (s, 3H), 2.55 (dd, J = 13.2, 4.1 Hz, 1H), 2.44 
(d, J = 17.2 Hz, 1H), 2.39–2.11 (m, 4H), 1.56–1.49 (m, 1H) ppm. 
13C NMR (150 MHz, CDCl3): δ = 174.7, 154.9, 153.7, 146.0, 139.4, 136.3, 128.7, 128.4, 128.3, 124.7, 
124.0, 111.6, 72.6, 71.2, 66.9, 66.6, 63.9, 60.7, 55.8, 46.1, 45.4, 40.6, 30.8, 28.2, 27.7 ppm. 
IR (ATR): ṽ = 3298 (w), 2942 (m), 2838 (w), 1721 (m), 1673 (s), 1601 (w), 1576 (w), 1526 (m), 1487 (s), 
1454 (m), 1421 (m), 1391 (m), 1372 (w), 1356 (w), 1340 (w), 1311 (w), 1273 (s), 1247 (s), 1172 (w), 1151 
(w), 1129 (w), 1107 (m), 1080 (s), 1070 (s), 1028 (w), 1015 (w), 1002 (w), 977 (m), 959 (m), 927 (w), 891 
(w), 863 (w), 834 (w), 814 (m), 751 (s), 697 (m), 665 (m) cm‒1.  
HRMS (ESI): calcd. for C19H25N2O5+:  479.2177 [M+H]+ 
found:    479.2178 [M+H]+. 
 
8',9'-Dimethoxy-12'-methyl-1',2'-dihydrospiro[oxazolidine-4,3'-[3a,9b](epiminoethano)cyclo-
penta[a]naphthalene]-2,11'-dione (22) 
 
BF3⋅OEt2, Ac2O
0 °C → r.t., 6.5 h
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Cbz-protected amine 21 (202 mg, 0.422 mmol, 1 eq.) was dissolved in Ac2O (10 mL) and cooled to 0 °C. 
After 15 min., BF3·OEt2 (535 µL, 4.22 mmol, 10 eq.) was added slowly. After 6.5 h, the reaction was 
quenched and diluted with wet EtOAc (10 mL) followed by aqueous 10% NaOH solution (50 mL). The 
mixture was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with saturated 
aqueous NaCl solution (50 mL), dried (MgSO4) and concentrated under reduced pressure. Flash column 
chromatography [DCM/acetone, 2:1 to 0:1] afforded oxazolidinone 22 (132 mg, 0.355 mmol, 84%) as a 
colorless solid. 
Crystals suitable for single-crystal X-ray analysis were obtained from recrystalization [CHCl3] at 20 °C. 
Rf = 0.65 [DCM/acetone, 1:3]. 
1H NMR (600 MHz, CDCl3) δ = 6.86 (d, J = 8.4 Hz, 1H), 6.80 (d, J = 8.4 Hz, 1H), 6.62 (d, J = 10.1 Hz, 
1H), 5.98 (d, J = 10.1 Hz, 1H), 5.61 (d, J = 11.2 Hz, 1H), 4.31 (d, J = 9.0 Hz, 1H), 3.90 (m, 4H), 3.88 (s, 
3H), 2.99 (m, 4H), 2.71 (d, J = 18.2 Hz, 1H), 2.66–2.56 (m, 1H), 2.03 (td, J = 13.3, 12.0, 6.8 Hz, 2H), 1.74 
(m, 2H). 
13C NMR (100 MHz, CDCl3): δ = 175.6, 158.3, 153.8, 146.7, 134.7, 130.1, 123.7, 122.2, 117.6, 111.3, 73.5, 
73.3, 71.1, 60.8, 55.9, 48.3, 45.7, 39.2, 32.3, 28.8 ppm. 
IR (ATR): ṽ = 3266 (w), 2946 (w), 1758 (s), 1674 (s), 1596 (w), 1490 (m), 1455 (m), 1422 (m), 1390 (m), 
1277 (s), 1217 (w), 1147 (w), 1090 (m), 1049 (m), 810 (w), 762 (w) cm‒1.  
HRMS (ESI): calcd. for C20H23N2O5+:  371.1601 [M+H]+ 
found:    371.1602 [M+H]+. 
 
t e r t-butyl 8',9'-dimethoxy-12'-methyl-2,11'-dioxo-1',2'-dihydrospiro[oxazoli-dine-4,3'-[3a,9b](epi-
minoethano)cyclopenta[a]naphthalene]-3-carboxylate (S4) 
 
Oxazolidinone 22 (202 mg, 0.545 mmol, 1.0 eq.) was dissolved in THF (25 mL) and Boc2O (238 mg, 
1.09 mmol, 2 eq.) followed by NEt3 (288 µL, 2.73 mmol, 2 eq.) and DMAP (6.66 mg, 54.4 µmol, 0.1 eq.) 
were added and the reaction stirred at room temperature for 17 h. Afterwards, the reaction mixture was 
Boc2O, DMAP
NEt3, THF, r.t., 17 h
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concentrated under reduced pressure and flash column chromatography [DCM/acetone, 1:0 to 1:1] 
afforded Boc-protected oxazolidonone S4 (173 mg, 0.356 mmol, 65%) as a colorless oil. 
Rf = 0.65 [DCM/acetone, 5:1]. 
1H NMR (400 MHz, CDCl3): δ = 6.85 (d, J = 8.3 Hz, 1H), 6.80 (d, J = 8.4 Hz, 1H), 6.58 (d, J = 10.1 Hz, 
1H), 5.95 (d, J = 10.1 Hz, 1H), 4.22 (d, J = 8.9 Hz, 1H), 3.92 (s, 3H), 3.87 (s, 3H), 3.76 (d, J = 9.0 Hz, 
1H), 3.18 (ddd, J = 14.7, 12.7, 6.7 Hz, 1H), 3.00 (d, J = 18.4 Hz, 1H), 2.87–2.80 (m, 4H), 2.73 (dd, 
J = 13.4, 6.6 Hz, 1H), 1.56 (s, 10H), 1.45 (dd, J = 8.0, 6.1 Hz, 1H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 174.9, 153.8, 153.5, 149.5, 146.7, 134.5, 129.9, 123.8, 121.9, 117.8, 
111.3, 85.1, 74.3, 73.6, 72.8, 60.8, 55.9, 48.1, 46.2, 38.4, 28.5, 28.2, 28.0 ppm. 
IR (ATR): ṽ = 2979 (w), 2939 (w), 1813 (s), 1734 (m), 1681 (s), 1596 (w), 1569 (w), 1490 (m), 1455 (m), 
1421 (w), 1393 (w), 1370 (w), 1329 (m), 1302 (s), 1276 (s), 1257 (s), 1150 (s), 1073 (s), 1060 (s), 964 (w), 
819 (w), 774 (w), 754 (m) cm‒1.  
HRMS (ESI): calcd. for C25H31N2O7+:  471.2126 [M+H]+ 
found:    471.2136 [M+H]+. 
 
t e r t-Butyl (3-formyl-8,9-dimethoxy-12-methyl-11-oxo-2,3-dihydro-1H-3a,9b-(epiminoethano)-
cyclopenta[a]naphthalen-3-yl)carbamate (23) 
 
Boc-protected oxazolidonone S4 (173 mg, 0.356 mmol, 1.0 eq.) was dissolved in MeOH (25 mL), then 
Cs2CO3 (58.5 mg, 0.178 mmol, 0.5 eq.) was added and the reaction stirred at room temperature for 12 h. 
The reaction mixture was diluted with saturated aqueous NaHCO3 solution (100 mL) and extracted with 
EtOAc (3 × 100 mL). The combined organic layers were washed with saturated aqueous NaCl solution 
(100 mL), dried (Na2SO4) and concentrated under reduced pressure. Flash column chromatography 
[DCM/acetone, 1:1 to 0:1] afforded aminoalcohol 23 (153 mg, 0.343 mmol, 96%) as a colorless oil. 
Rf = 0.88 [acetone/DCM, 2:1]. 
1H NMR (400 MHz, CDCl3) δ = 6.76 (m, 2H), 6.42 (d, J = 10.1 Hz, 1H), 6.16 (d, J = 10.2 Hz, 1H), 4.64 
(s, 1H), 4.25 (d, J = 12.2 Hz, 1H), 3.90 (s, 3H), 3.86 (s, 3H), 3.39 (d, J = 12.2 Hz, 1H), 3.04 (d, 
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J = 18.4 Hz, 1H), 2.97 (s, 3H), 2.77 (d, J = 18.4 Hz, 1H), 2.46 (ddd, J = 13.5, 6.7, 4.2 Hz, 1H), 2.0–2.00 
(m, 1H), 1.95 (ddd, J = 11.3, 6.5, 4.2 Hz, 1H), 1.65 (td, J = 11.5, 7.2 Hz, 1H), 1.45 (s, 9H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 175.9, 155.4, 153.4, 146.5, 135.6, 128.3, 123.1, 122.6, 120.1, 111.0, 80.5, 
76.11, 70.9, 60.7, 60.6, 55.9, 49.0, 47.9, 40.0, 30.7, 28.5, 28.4 ppm. 
IR (ATR): ṽ = 3356 (w), 2976 (w), 2939 (w), 1711 (m), 1669 (s), 1597 (w), 1570 (w), 1530 (w), 1490 (m), 
1455 (m), 1421 (w), 1393 (m), 1366 (m), 1274 (s), 1249 (m), 1166 (s), 1116 (w), 1052 (m), 962 (w), 867 (w), 
917 (w), 754 (m), 678 (w) cm‒1.  
HRMS (ESI): calcd. for C24H33N2O6+:  445.2333 [M+H]+ 
found:    445.2338 [M+H]+. 
 
t e r t-Butyl (3-formyl-8,9-dimethoxy-12-methyl-11-oxo-2,3-dihydro-1H-3a,9b-(epiminoethano)-
cyclopenta[a]naphthalen-3-yl)carbamate (24) 
 
Alcohol 23 (153 mg, 0.343 mmol, 1.0 eq.) was dissolved in DCM (18 mL) and NMO (417 mg, 3.56 mmol, 
10.4 eq.) followed by TPAP (6.26 mg, 17.8 µmol, 0.5 eq.) was added to the solution. The reaction stirred 
at room temperature for 1 h. Afterwards, the reaction mixture was filtered over a pad of silica and the 
silica was washed with DCM (10 mL) and acetone (10 mL) to afford aminoaldehyde 24 (122 mg, 
0.276 mmol, 80%) as a colorless oil. 
Rf = 0.75 [DCM/acetone, 2:1]. 
1H NMR (400 MHz, CDCl3) δ = 9.55 (s, 1H), 6.88–6.75 (m, 2H), 6.48 (d, J = 10.0 Hz, 1H), 5.87 (d, 
J = 10.0 Hz, 1H), 5.11 (s, 1H), 3.92 (s, 3H), 3.87 (s, 3H), 3.07 (d, J = 18.4 Hz, 1H), 2.92 (s, 3H), 2.82 (d, 
J = 18.5 Hz, 1H), 2.50 (dt, J = 12.9, 5.1 Hz, 1H), 2.20–2.13 (m, 1H), 2.13–2.03 (m, 1H), 1.94 (dt, J = 10.7, 
5.2 Hz, 1H), 1.45 (s, 9H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 198.5, 175.3, 155.1, 153.6, 146.5, 134.8, 129.2, 123.5, 122.7, 119.3, 
111.2, 81.2, 75.7, 75.0, 60.8, 55.9, 48.0, 39.0, 30.0, 29.9, 28.4, 27.9 ppm. 
IR (ATR): ṽ = 3399 (bw), 2927 (m), 2851 (w), 1734 (w), 1673 (s), 1525 (m), 1490 (m), 1455 (m), 1421 (w), 
1394 (w), 1367 (w), 1276 (s), 1165 (s), 1099 (w), 1066 (m), 1046 (w), 969 (w), 817 (w), 679 (w) cm‒1.  
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HRMS (ESI): calcd. for C24H3qN2O6+:  443.2177 [M+H]+ 
found:    443.2179 [M+H]+. 
 
13-Iodo-4,5-dimethoxy-1-methyl-1H ,8H ,9aH-3a,12a-ethano-8,12b-methano-benzo[6,7]-
pyrrolo[2',3':4,5]oxocino[3,2-d]oxazole-2,11(3H ,12H)-dione (25) 
 
Aminoaldehyde 24 (3.5 mg, 7.9 mmol, 1.0 eq.) was dissolved in MeCN/H2O (5:1, 2.4 mL) then I2 (8.9 mg, 
79 mmol, 10 eq.) was added and the reaction stirred at room temperature for 24 h. Afterwards, the 
reaction was stopped by the addition of aqueous saturated Na2S2O7 (1 mL) and diluted with H2O (10 mL). 
Then, the mixture was extracted with DCM (3 × 10 mL) and the combined organic layers were washed 
with saturated aqueous NaCl solution (10 mL), dried (MgSO4) and concentrated under reduced pressure. 
Flash column chromatography [DCM/acetone, 1:0 to 2:1] afforded hexacyclic oxazolidinone 25 (3.5 mg, 
7.2 mmol, 91%) as a yellow oil. 
Rf = 0.61 [DCM/acetone, 2:1]. 
1H NMR (400 MHz, CDCl3): d = 7.07 (d, J = 8.4 Hz, 1H), 6.94 (d, J = 8.4 Hz, 1H), 5.59 (d, J = 3.9 Hz, 
1H), 5.19 (d, J = 3.5 Hz, 1H), 5.13 (s, 1H), 5.08 (d, J = 3.6 Hz, 1H), 3.94 (s, 3H, H-20), 3.91 (s, 3H), 3.11 
(d, J = 17.5 Hz, 1H), 3.01 (d, J = 17.7 Hz, 1H), 2.96 (s, 3H), 2.39 (dd, J = 14.8, 9.4 Hz, 1H), 2.16–2.06 (m, 
1H), 2.06–1.97 (m, 1H), 1.92 (dd, J = 12.8, 8.7 Hz, 1H) ppm. 
13C NMR (101 MHz, CDCl3): d = 175.5, 157.5, 154.4, 145.9, 136.0, 126.4, 120.6, 112.2, 97.5, 76.7, 72.2, 
70.8, 60.8, 55.9, 47.8, 46.5, 40.5, 32.7, 27.2, 24.5 ppm. 
IR (ATR): ṽ = 1934 (m), 2362 (w), 1778 (s), 1684 (s), 1601 (w), 1490 (m), 1457 (m), 1423 (w), 1362 (m), 
1278 (s), 1212 (w), 1119 (w), 1089 (m), 1034 (s), 979 (m), 954 (w), 929 (w), 800 (w), 752 (w), 683 (w) cm‒1.  
HRMS (ESI): calcd. for C20H22IN2O6: : 513.0517 [M+H]+  
found:    513.0525 [M+H]+. 
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Methyl 3-((t e r t-butoxycarbonyl)amino)-8,9-dimethoxy-12-methyl-11-oxo-2,3-dihydro-1H-3a,9b-
(epiminoethano)cyclopenta[a]naphthalene-3-carboxylate (26) 
	  
Aminoaldehyde 24 (122 mg, 0.276 mmol, 1.0 eq.) was dissolved in MeOH (20 mL), then I2 (660 mg, 
2.76 mmol, 10 eq.) was added and the reaction stirred at room temperature for 30 min. Afterwards, the 
reaction was stopped by the addition of aqueous saturated Na2S2O7 solution (2 mL) and diluted with H2O 
(30 mL). Then, the mixture was extracted with DCM (3 × 50 mL) and the combined organic layers were 
washed with saturated aqueous NaCl solution (100 mL), dried (MgSO4) and concentrated under reduced 
pressure. Flash column chromatography [DCM/acetone, 10:1 to 5:1] afforded ester 26 (123 mg, 
0.260 mmol, 94%) as a yellow oil. 
Rf = 0.65 [DCM/acetone, 5:1]. 
1H NMR (400 MHz, CDCl3) δ = 6.83–6.66 (m, 2H), 6.44 (d, J = 10.0 Hz, 1H), 5.52 (d, J = 10.0 Hz, 1H), 
4.95 (s, 1H), 3.94 (s, 3H), 3.86 (s, 3H), 3.77 (s, 3H), 3.16 (d, J = 18.4 Hz, 1H), 3.02 (s, 3H), 2.71 (d, 
J = 18.4 Hz, 1H), 2.40 (dd, J = 12.5, 5.8 Hz, 1H), 2.36–2.27 (m, 1H), 2.24 (dd, J = 13.0, 5.1 Hz, 1H), 2.14–
2.02 (m, 1H), 1.43 (s, 9H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 175.5, 172.4, 154.5, 153.8, 146.4, 135.0, 130.2, 123.1, 122.7, 117.5, 
111.2, 80.8, 76.0, 72.7, 60.8, 55.9, 52.5, 48.2, 48.1, 42.1, 33.1, 28.4, 27.2 ppm. 
IR (ATR): ṽ = 3297(w), 2978 (w), 2945 (w), 2840 (w), 1789 (w), 1681 (s), 1596 (w), 1572 (w), 1491 (m), 
1455 (s), 1421 (m), 1391 (m), 1367 (m), 1274 (s), 1248 (s), 1213 (m), 1163 (s), 1126 (m), 1089 (m), 1033 
(m), 1063 (m), 1033 (m), 981 (m), 955 (m), 929 (w), 879 (w), 817 (m), 753 (s), 666 (w), 617 (w) cm‒1.  
HRMS (ESI): calcd. for C25H33N2O7+:  473.2282 [M+H]+ 
found:    473.2287 [M+H]+. 
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t e r t-Butyl (14-bromo-10,11-dimethoxy-3-methyl-2,5-dioxo-2,3-dihydro-1H , 7H-4,11b-ethano-3a,7-
methanobenzo[6,7]oxocino[4,5-b]pyrrol-4(5H)-yl)carbamate (28) 
	  
Ester 26 (123 mg, 0.260 mmol, 1.0 eq.) was dissolved in THF (8 mL) in a flask covered with aluminium 
foil, then NBS (48.6 mg, 0.273 mmol, 1.05 eq.) in H2O (8 mL) was added and the reaction stirred at 0 °C 
for 90 minutes and at room temperature for another 90 minutes. Afterwards, the reaction was stopped by 
the addition of aqueous saturated Na2S2O7 (2 mL) and diluted with H2O (50 mL). Then, the mixture was 
extracted with DCM (3 × 50 mL) and the combined organic layers were washed with saturated aqueous 
NaHCO3 solution (5 × 50 mL) and saturated aqueous NaCl solution (50 mL), dried (MgSO4) and 
concentrated under reduced pressure. Flash column chromatography [PE/EtOAc, 1:0 to 1:2] afforded 
bromolactone 28 (69.3 mg, 0.129 mmol, 50%) as a colorless solid. 
Rf = 0.61 [DCM/acetone, 3:1]. 
1H NMR (400 MHz, CDCl3) δ = 7.06 (d, J = 8.3 Hz, 1H), 6.87 (d, J = 8.4 Hz, 1H), 6.09 (d, J = 4.7 Hz, 
1H), 5.65 (d, J = 4.6 Hz, 1H), 5.04 (s, 1H), 3.90 (s, 3H), 3.89 (s, 3H), 3.16 (d, J = 18.0 Hz, 1H), 3.04 (s, 
3H), 2.88 (d, J = 18.0 Hz, 1H), 2.43–2.34 (m, 1H), 2.34–2.26 (m, 1H), 2.08 (td, J = 11.8, 7.2 Hz, 1H), 1.98 
(td, J = 12.1, 6.7 Hz, 1H), 1.47 (s, 9H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 176.2, 169.9, 155.6, 154.7, 145.9, 135.4, 125.6, 122.7, 111.3, 82.1, 78.7, 
75.8, 71.3, 60.8, 55.9, 49.3, 47.5, 44.7, 39.8, 38.1, 29.7, 28.4 ppm. 
IR (ATR): ṽ = 2928 (w), 1702 (w), 1746 (m), 1699 (s), 1684 (s), 1602 (w), 1589 (w), 1521 (w), 1491 (m), 
1457 (m), 1426 (w), 1391 (w), 1369 (m), 1274 (s), 1232 (w), 1161 (m), 1121 (m), 1025 (m), 983 (m), 814 
(m), 806 (m) cm‒1.  
HRMS (ESI): calcd. for C24H30N2O7Br+:  537.1231 [M+H]+ 
found:     537.1234 [M+H]+. 
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t e r t-Butyl (10,11-dimethoxy-3-methyl-2,5-dioxo-2,3-dihydro-1H ,7H-4,11b-ethano-3a,7-methano-
benzo[6,7]oxocino[4,5-b]pyrrol-4(5H)-yl)carbamate (29) 
	  
Bromide 28 (41.6 mg, 77.4 µmol, 1.0 eq.) was dissolved in toluene (4 mL) and AIBN (12.7 mg, 77.4 µmol, 
1 eq.) followed by Bu3SnH (210 µL, 225 mg, 0.774 mmol, 10 eq.) were added. The reaction mixture was 
degassed using three freeze-pump-thaw cycles. The reaction was then placed in a 90 °C oil bath and 
stirred at this temperature for 3 h. After cooling to room temperature, the solvent was removed under 
reduced pressure. Flash column chromatography on silica/K2CO3, 9:1 [Pent/EtOAc, 1:1 to 0:1] afforded 
lactone 29 (34.7 mg, 75.7 µmol, 98%) as a colorless solid.  
Crystals suitable for single-crystal X-ray analysis were obtained from recrystallization [CHCl3] at 20 °C. 
Rf = 0.26 [EA/Pent, 5:1]. 
1H NMR (400 MHz, CDCl3) δ = 7.04 (d, J = 8.3 Hz, 1H), 6.83 (d, J = 8.4 Hz, 1H), 5.54 (d, J = 4.5 Hz, 
1H), 5.00 (s, 1H), 3.89 (s, 3H), 3.88 (s, 3H), 3.77 (dd, J = 13.1, 4.7 Hz, 1H), 3.20 (d, J = 18.2 Hz, 1H), 3.03 
(s, 3H), 2.80 (d, J = 19.9 Hz, 1H), 2.33–2.22 (m, 2H), 2.04–1.93 (m, 2H), 1.78 (d, J = 12.9 Hz, 1H), 1.46 (s, 
9H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 175.3, 171.3, 155.6, 154.4, 146.7, 135.6, 126.4, 124.5, 111.2, 81.4, 76.3, 
72.5, 69.5, 60.8, 55.9, 49.7, 46.1, 39.2, 37.5, 29.3, 28.4 ppm. 
IR (ATR): ṽ = 3339 (w), 2976 (w), 2934 (w), 1683 (s), 1603 (w), 1581 (w), 1526 (w), 1491 (m), 1457 (m), 
1424 (w), 1392 (m), 1368 (m), 1329 (w), 1273 (s), 1244 (m), 1162 (m), 1125 (m), 1072 (m), 1026 (w), 1004 
(w), 987 (w), 974 (w), 950 (w), 922 (w), 816 (w), 754 (m), 685 (m), 667 (w) cm‒1.  
HRMS (ESI): calcd. for C24H31N2O7+:   459.2126 [M+H]+ 
found:     459.2129 [M+H]+. 
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t e r t -Butyl (10,11-dimethoxy-3-methyl-5-oxo-2,3-dihydro-1H,7H-4,11b-ethano-3a,7-methanoben-
zo[6,7]oxocino[4,5-b]pyrrol-4(5H)-yl)carbamate (S5) 
	  
In six reaction vials in parallel, Lactam 29 (6 × 1.0 mg, 13 mmol, 1.0 eq.) was dissolved in THF 
(6 × 200 µL) and the reaction mixture was cooled to 0 °C. DMS· BH3 (0.11 M stock solution in THF, 
6 × 0.19 mL, 0.13 mmol, 10 eq.) was added and the reaction stirred for 20 h under an Ar atmosphere, 
while warming to room temperature. After 20 h, the reaction was cooled again to 0 °C, 2 drops of AcOH 
were added to every reaction vial and the resulting solutions were stirred at 0 °C for 30 min. The reactions 
were combined and diluted with EtOAc (20 mL) and washed with aqueous saturated NaHCO3 (20 mL). 
Then, the aqueous phase was extracted with EtOAc (3 × 30 mL) and the combined organic layers were 
dried (Na2SO4) and concentrated under reduced pressure. Flash column chromatography [Pent/EtOAc, 
1:1 to 0:1] afforded pyrrolidine S5 (3.3 mg, 7.4 µmol, 57%, 99% brsm) as a colorless solid. 
Rf = 0.55[EA/Pent, 5:1]. 
1H NMR (400 MHz, CDCl3) δ = 6.98 (d, J = 8.3 Hz, 1H), 6.77 (d, J = 8.3 Hz, 1H), 5.51 (d, J = 4.5 Hz, 
1H), 5.10 (s, 1H), 3.86 (s, 3H), 3.85 (s, 3H), 3.16 (d, J = 12.9 Hz, 1H), 3.06 (ddd, J = 9.5, 7.7, 2.0 Hz, 1H), 
2.53 (ddd, J = 13.0, 7.3, 2.0 Hz, 1H), 2.47–2.35 (m, 4H), 2.32–2.15 (m, 4H), 1.84 (dd, J = 13.0, 1.5 Hz, 
1H), 1.73–1.63 (m, 1H), 1.45 (s, 9H) ppm. 
13C NMR (101 MHz, CDCl3): d = 172.5, 154.3, 147.1, 138.4, 127.4, 124.0, 110.4, 78.0, 71.6, 69.4, 60.7, 
56.8, 55.9, 55.7, 40.4, 39.6, 37.3, 36.8, 28.5, 23.3 ppm. Note: The signal of the carbamate-group was not visible in 
the 13C NMR. 
IR (ATR): ṽ = 3351 (w), 2937 (w), 2792 (w), 1706 (s), 1602 (w), 1579 (w), 1488 (m), 1455 (m), 1422 (w), 
1392 (w), 1366 (s), 1327 (w), 1270 (s), 1236 (m), 1217 (m), 1159 (s), 1119 (s), 1079 (m), 1057 (m), 1039 
(m), 994 (m), 950 (m), 937 (m), 921 (m), 860 (m), 812 (m), 799 (m), 748 (s), 722 (m), 666 (m) cm‒1. 
HRMS (ESI): calcd. for C24H33N2O6+:   445.2333 [M+H]+ 
found:     445.2330 [M+H]+. 
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O (57%, 99% brsm)
DMS⋅BH3, THF
0 °C → r.t., 20 h
S5
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Stephadiamine (3) 
	  
Boc-protected diamine S5 (5.1 mg, 12 µmol, 1 eq.) was dissolved in deuterated DCM (0.5 mL) in an NMR 
tube and cooled to 0 °C. TFA (5.1 mg, 0.12 mmol, 10 eq.) was added and the reaction was kept at 0 °C. 
The reaction process was monitored by NMR. After 300 min, aqueous saturated NaHCO3 (20 mL) was 
added and the aqueous phase was extracted with EtOAc (3 × 20 mL). The combined organic phases were 
dried (Na2SO4) and the solvent was evaporated to give crude stephadiamine (3, 4.2 mg, <90%) as a 
colorless solid. 
NOTE: Multiple purification methods such as a variety of work-up procedures, manual normal phase conditions and 
reversed phase HPLC conditions (buffered and unbuffered) led to decomposition of the material, therefore a crude spectrum of 
the natural product after basic work-up is presented. 
Rf = 0.43 [DCM/MeOH/NH4OH, 95:5:1]. 
1H NMR (400 MHz, CDCl3) δ = 7.01 (d, J = 8.4 Hz, 1H), 6.81 (d, J = 8.3 Hz, 1H), 5.40 (dd, J = 4.2, 
2.1 Hz, 1H), 3.87 (s, 3H), 3.87 (s, 3H), 3.33 (ddd, J = 9.3, 7.8, 4. Hz, 1H), 2.62–2.52 (m, 5H), 2.52 – 2.42 
(m, 1H), 2.37–2.28 (m, 1H), 2.24 (ddd, J = 13.1, 8.7, 4.2 Hz, 1H), 2.07 (dt, J = 13.5, 6.9 Hz, 1H), 2.00–
1.89 (m, 2H), 1.80 (dt, J = 13.0, 7.3 Hz, 1H) ppm. 
13C NMR (101 MHz, CDCl3): δ = 175.9, 154.4, 147.1, 137.4, 126.2, 124.7, 110.9, 76.6, 71.7, 70.1, 60.7, 
57.3, 55.9, 41.8, 38.8, 38.6, 37.5, 24.1 ppm. 
IR (ATR): ṽ = 3382 (wb), 2961 (m), 2925 (m), 2855 (m), 1726 (m), 1678 (m), 1491 (w), 1462 (m), 1424 
(w), 1370 (m), 1328 (m), 1258 (s), 1201 (m), 1180 (m), 1092 (s), 1019 (s), 798 (s), 758 (m), 721 (m) cm‒1.  
HRMS (ESI): calcd. for C19H25N2O4+:   345.1809 [M+H]+ 
found:     345.1809 [M+H]+. 
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0 °C, 300 min
stephadiamine (3)
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1H NMR monitoring of the final deprotection in CD2Cl2 
 
Comparison of NMR data with isolation data in CDCl3 
NOTE: Synthetic stephadiamine (3) as a free base was highly unstable in commercially available CDCl3. In order to 
circumvent protonation by traces of acid, molecular sieves (4 Å, activated) were added to CDCl3 (100 mL bottle). The bottle 
was flushed with argon and stored over night at 4 °C. Immediately prior to recording the spectra, CDCl3 (12 mL) was 
filtered over basic Al2O3 (1.5 cm pad in a Pasteur pipette) and the first 2 mL of CDCl3 were discarded. The crude 
stephadiamine sample was coevaporated with purified CDCl3 (3 × 3 mL) to remove other trace solvents. Afterwards, the 
NMR spectra were immediately recorded in purified CDCl3 (0.5 mL). 
It is noteworthy that this procedure led to impurities visible in the 1H NMR spectrum in the range of 0−1.6 ppm. A 
comparison of these signals with a blank sample of CDCl3 that was basified according to the procedure described above led to 
the conclusion that these impurities stem from the basic Al2O3. 
  
+TFA_60 min
(product formation indicated in red)
Starting material in d2-DCM
+TFA_180 min
+TFA_300 min
Boc
benzylic proton
N-Me
N-Me
N-Me
Boc
Boc
benzylic proton
benzylic proton
N-Me
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Natural, 1H NMR (CDCl
3
) 
δ/ppm 
Synthetic, 1H NMR (CDCl
3
, 400 MHz) 
δ/ppm 
7.00 (d, J = 8.0 Hz) 7.01 (d, J = 8.4 Hz) 
6.80 (d, J = 8.0 Hz) 6.81 (d, J = 8.3 Hz) 
5.39 (dd, J = 4.3, 2.0 Hz) 5.40 (dd, J = 4.2, 2.1 Hz) 
3.87 (s) 3.87 (2s) 
2.54 (s) 2.57 (s) 
 
Note: See characterization data for the full list of 1H and 13C NMR signals. 
 	
Asymmetric studies for the synthesis of α-allylcyclohexanone 8 
Experiments with chiral ligands and chiral organocatalysts were carried out using the following HPLC 
parameters to determine the enantiomeric excess: 
Chiral HPLC:    Retention time (R)-8: 10.438 min (IB) 
Retention time (S)-8: 12.365 min (IB) 
Retention time (R)-8: 7.886 min (OD-3) 
Retention time (S)-8: 9.389 min (OD-3) 
Column:  DAICEL CHIRALPAK® IB or OD-3 
Flow rate:  1 mL/min  
Mobile phase:  n-hept:iso-prop 97.5:2.5 (v/v) for IB, n-hept:iso-prop 98:2 (v/v) for OD-3 
Temperature:  20 °C 
Wavelenghth:  198 nm. 
(R)-8: [a]D = +0.40 (c = 1, DCM). 
Crystals suitable for single-crystal X-ray analysis and the determination of the absolute stereochemistry of 
both enantiomers were obtained from recrystallization [Et2O/n-heptane, 3:10] at 4 °C. The ee was 98% 
after recrystallization and the mother liquor contained the racemate. 	
A) Asymmetric α-allylation v ia  decarboxylative Tsuji allylation 
Optimization studies for the asymmetric synthesis of 8 	
Procedure A: The reaction was carried out at a concentration of 0.030 M in a glovebox under nitrogen 
atmosphere. Tris(dibenzylideneacetone)dipalladium(0) (1.50 µmol, 5 mol%) and a ligand (3.75 µmol, 
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12.5 mol%) were dissolved in dry, degassed solvent and the catalyst stirred for 30 min at 25 °C. A solution 
of carbonate 31 (10.0 mg, 30.0 µmol, 1 eq.) in solvent was added to the preformed catalyst and the 
reaction was stirred at a set temperature T, prior to dilution of the sample with hexanes and ether, 
filtration over silica and analysis of the %ee by chiral HPLC. 
	 	
Entrya)  L igand Solvent T (°C) t (h) %ee  
1 (S)-t-Bu-PHOX (L1 ) THF 25 20 3 
2 (S)-t-Bu-PHOX (L1 ) toluene 25 20 1 
3 (S)-t-Bu-PHOX (L1 ) 2:1 hexane/toluene 25 20 6 
4 (S)-CF3-t-Bu-PHOX (L2) THF 25 20 10 
5 (S)-CF3-t-Bu-PHOX (L2) toluene 25 20 26 
6 (S)-CF3-t-Bu-PHOX (L2) 2:1 hexane/toluene 25 20 38 
7 (R,R)-ANDEN-Phenyl Trost (L5 ) THF 25 20 22 
8 (R,R)-ANDEN-Phenyl Trost (L5 ) toluene 25 20 13 
9 (R,R)-ANDEN-Phenyl Trost (L5 ) 2:1 hexane/toluene 25 20 25 
10b) (S)-QUINAP (L3 ) THF 25 20 14 
11b) (S)-QUINAP (L3 ) toluene 25 20 3 
12b) (S)-QUINAP (L3 ) 2:1 hexane/toluene 25 20 11 
13 (S)-CF3-t-Bu-PHOX (L2) 2:1 hexane/toluene 20 14 39 
14 (S)-CF3-t-Bu-PHOX (L2) 2:1 hexane/toluene 0 14 42 
15 (S)-CF3-t-Bu-PHOX (L2) 2:1 hexane/toluene −15 14 34 
16 (S)-CF3-t-Bu-PHOX (L2) 2:1 hexane/toluene −60 14 37 
a) Full conversion by 1HPLC was observed for all cases. 
b) (R)-8 was observed as the major enantiomer. 
 
Procedure B: The reaction was carried out at a concentration of 0.030 M in a glovebox under nitrogen 
atmosphere. To tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct (A, 1.65 µmol, 5.5 mol%) or 
tris(dibenzylideneacetone)dipalladium(0) (B, 1.65 µmol, 5.5 mol%) and a ligand (3.30 µmol, 11.0 mol%) a 
dry, degassed solvent was added and the catalyst stirred for 30 min at 25 °C. A solution of carbonate 31 
(10.0 mg, 30.0 µmol, 1 eq.) in solvent was added to the preformed catalyst and the reaction was stirred at 
the designated temperature for the designated time, prior to dilution of the sample with hexanes and ether 
and analysis of the %ee by chiral HPLC. 
Pd2(dba)3 (5 mol%)
ligand (12.5 mol%)
solvent, T, t
O
OMe
MeO
NC
OO
31
OMe
MeO
O
NC
(S)-8
 S33 
	 	
Entrya)  Ligand  Pd source  Solvent  T (°C)  t  (h)  %ee  
1 (R,R)-DACH-Phenyl Trost (L6 ) A DME 25 12 51 
2 (R,R)-DACH-Phenyl Trost (L6 ) A MTBE 25 12 46 
3 (R,R)-DACH-Phenyl Trost (L6 ) A THF 25 12 47 
4 (R,R)-DACH-Phenyl Trost (L6 ) A toluene 25 12 52 
5 (R,R)-DACH-Phenyl Trost (L6 ) A 2:1 hexane/toluene 25 12 53 
6 (R,R)-DACH-Naphthyl Trost (L4 ) A DME 25 12 22 
7 (R,R)-DACH-Naphthyl Trost (L4 ) A MTBE 25 12 24 
8 (R,R)-DACH-Naphthyl Trost (L4 ) A THF 25 12 24 
9 (R,R)-DACH-Naphthyl Trost (L4 ) A toluene 25 12 26 
10 (R,R)-DACH-Naphthyl Trost (L4 ) A 2:1 hexane/toluene 25 12 29 
11 (R,R)-ANDEN-Phenyl Trost (L5 ) A DME 25 12 6 
12 (R,R)-ANDEN-Phenyl Trost (L5 ) A MTBE 25 12 24 
13 (R,R)-ANDEN-Phenyl Trost (L5 ) A THF 25 12 25 
14 (R,R)-ANDEN-Phenyl Trost (L5 ) A toluene 25 12 13 
15 (R,R)-ANDEN-Phenyl Trost (L5 ) A 2:1 hexane/toluene 25 12 27 
16 (R,R)-DACH-Phenyl Trost (L6 ) A THF −15 24 48 
17 (R,R)-DACH-Phenyl Trost (L6 ) A 2:1 hexane/toluene −15 24 66 
18 (R,R)-DACH-Phenyl Trost (L6 ) A THF −60 24 46 
19 (R,R)-DACH-Phenyl Trost (L6 ) A 2:1 hexane/toluene −60 24 55 
20 (R,R)-DACH-Phenyl Trost (L6 ) A THF −78 24 54 
21 (R,R)-DACH-Phenyl Trost (L6 ) A 2:1 hexane/toluene −78 24 54 
22 (R,R)-DACH-Phenyl Trost (L6 ) A toluene −10 2 60 
23 (R,R)-DACH-Phenyl Trost (L6 ) A 2:1 hexane/toluene −10 2 66 
24 (R,R)-DACH-Phenyl Trost (L6 ) B toluene −10 2 64 
25 (R,R)-DACH-Phenyl Trost (L6 ) B 2:1 hexane/toluene −10 2 59 
26b) (R,R)-DACH-Phenyl Trost (L6 ) B toluene −10 2 64 
25c) (R,R)-DACH-Phenyl Trost (L6 ) B toluene −10 2 17 
a) Full conversion by 1HPLC was observed for all cases. 
b) Pd
2
dba
3
 to ligand ratio of 1:2.2 
c) Pd
2
dba
3
 to ligand ratio of 1:4.4 
 
 
(A) Pd2(dba)3独CHCl3 or (B) Pd2(dba)3 (5.5 mol%)
ligand (11 mol%)
solvent, T, t
OMe
MeO
O
NC
O
OMe
MeO
NC
OO
31 (S)-8
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Procedure C: The reaction was carried out at given concentrations in a glovebox under nitrogen 
atmosphere. To tris(dibenzylideneacetone)dipalladium(0) and ligand a solvent was added and the catalyst 
was stirred for 30 min at 25 °C. A solution of carbonate 31 (10.0 mg, 0.030 mmol, 1 eq.) in solvent was 
added to the preformed catalyst and the reaction was stirred at the designated temperature for the 
designated time, prior to dilution of the sample with hexanes and ether and analysis of the %ee by chiral 
HPLC. 
	 	
Entrya)  Conc. (M)  Pd2(dba)3 Solvent  T (°C)  t  (h)  %ee  
1 0.03 5 mol% toluene −10 2 64 
2 0.03 5 mol% 2:1 hexane/toluene −10 2 59 
3 0.01 5 mol% toluene −10 2 66 
4 0.01 5 mol% 2:1 hexane/toluene −10 2 58 
5 0.001 5 mol% toluene −10 2 66 
6 0.001 5 mol% 2:1 hexane/toluene −10 2 62 
7 0.03 1 mol% toluene −10 2 60 
8 0.03 1 mol% 2:1 hexane/toluene −10 2 66 
9 0.03 5 mol% toluene −30 2 50 
10 0.03 5 mol% 2:1 hexane/toluene −30 2 64 
a) Full conversion by 1HPLC was observed for all cases. 
 
Procedure D: The reaction was carried out at a concentration of 0.18 M in a glovebox under nitrogen 
atmosphere. Ketone I.226 (38 mg, 0.16 mmol, 1 eq.) and Cs2CO3 (51 mg, 0.16 mmol, 1 eq.) were 
dissolved in degassed DME (0.5 mL) and stirred at room temperature for 15 min. before being cooled to 
-78 °C. In a second flask, allylpalladium (II) chloride dimer [(η3-C3H5)PdCl]2 (1.4 mg, 3.9 µmol, 2.5 mol%) 
and ligand (7.8 µmol, 5.0 mol%) were dissolved in DME (0.4 mL) and stirred at room temperature for 
15 min. before allyl acetate (18 µL, 0.17 µmol, 1.1 eq.) was added. Stirring was continued for another 
5 min., then the preformed catalyst was slowly added via syringe into the enolate solution at -78 °C. The 
mixture was slowly allowed to warm to 0 °C and stirred at this temperature for 12 h, prior to dilution of 
the sample with hexanes and ether and analysis of the %ee by chiral HPLC. 
(Pd2(dba)355'$&+
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31 (S)-8
 S35 
	 	
Entrya)  L igand Solvent T (°C) t (h) %eeb)  
1 (R,R)-DACH-Phenyl Trost (L6 ) DME 0 12 7 
2 (R,R)-DACH-Naphthyl Trost (L4 ) DME 0 12 5 
3 (R,R)-ANDEN-Phenyl Trost (L5 ) DME 0 12 2 
a) Full conversion by 1HPLC was observed for all cases. 
b) Absolute stereochemistry was not determined at this stage 
Optimized Procedure for the Asymmetric Synthesis of (R)-8 v ia  Decarboxylative Tsuji Allylation 
	
Tris(dibenzylideneacetone)dipalladium(0) (2.78 mg, 3.04 µmol, 1 mol%) and (S,S)-DACH Trost ligand 
(4.20 mg, 6.08 µmol, 2.2 mol%) were dissolved in degassed toluene and hexane (1:1, 100 mL) and stirred 
at room temperature for 30 min, before the mixture was cooled to −10 °C. A solution of carbonate 31 
(100 mg, 0.304 mmol, 1.0 eq.) dissolved in degassed toluene and hexane (1:1, 5 mL) was added to the 
preformed catalyst and the reaction was stirred at room temperature for 5 min prior to concentrating the 
reaction mixture under reduced pressure. Flash column chromatography [PE/EtOAc, 9:1] afforded (R)-8 
(84.2 mg, 0.295 mmol, 97%). 
Crystals suitable for single-crystal X-ray analysis and the determination of the absolute stereochemistry of 
both enantiomers were obtained from recrystallization [Et2O/n-heptane, 3:10] at 4 °C. The ee was 98% 
after recrystallization and the mother liquor contained the racemate. 
(R)-8: [a]D = +0.40 (c = 1, DCM). 	
B) Asymmetric α-allylation v ia  asymmetric counterion-directed catalysis 
Optimization studies for the asymmetric synthesis of (S)-8 using counterion-directed catalysis 
 
Unless otherwise stated , all reactions were performed on a 0.05 mmol scale of substrate using 10 mol% 
of the chiral acid catalyst, 2.5% of palladium catalyst, 11 mol%  of phosphine,  3 equivalents of 
[(!3-C3H5)PdCl]2 (2.5 mol%)
ligand (5.5 mol%) 
allyl acetate (1.1 eq.), Cs2CO3 
(2.2 eq.), solvent, t, T
OMe
MeO
O
NC
O
OMe
MeO
NC
832
(S,S)-DACH Trost 
ligand (2 mol%), 
Pd2(dba)3 (1 mol%)
tol:hex 1:2, 
-10 °C, 5 min
OMe
MeO
O
NC
O
OMe
MeO
NC
OO
(97%)
ee = 66%
ee after recrystalli-
zation: 98%31 (R)-8
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electrophile, 3 Å MS (1000mg/mmol) and cyclohexane as solvent. The undesired regioisomer was never 
detected in the reaction mixture. 
 
 
 
a) Full conversion by 1H-NMR was observed unless otherwise noted. 
b) Methylcyclohexane was used as solvent 
c) 63% conversion (determined by 1H NMR), 63% isolated yield 
d) 85% conversion (determined by 1H NMR), 81% isolated yield 	
General Procedure for the Asymmetric Synthesis of 8 v ia  Enol Catalysis 
 
In a 10 ml vial, ketone 32 (30.6 mg, 0.125 mmol, 1 eq.), 3 Å MS (1.00 g/mmol substrate), (S)-H8-TRIP 
(10 mol%), tBuXPhos (11 mol%), Pd2(dba)3 (2.5 mol%.) were dissolved in cyclohexane (6.25 mL, 0.01 M). 
To this solution, allyl methyl carbonate (3 eq.) was added and the vial was sealed. The reaction mixture 
was then stirred at 15 °C for 120 h. The reaction was quenched by passing it through a short silica plug 
and eluted with ether. After evaporation of the solvent, the crude mixture was directly purified by flash 
column chromatography [pentane/Et2O, 95:5 to 60:40] to afford allyl cyclohexanone (S)-8 in 93% ee 
(22.4 mg, 0.079 mmol, 63% yield, 97% brsm, 93% ee). 
Using the same procedure but running the reaction at 10 °C, 0.02 M and employing (R)-H8-TRIP as 
catalyst, (R)-8 was obtained in 90% ee (29.0 mg, 0.102 mmol, 81% yield, 96% brsm). 
allyl carbonate (3 eq.)
A or B (10 mol%)
Pd2(dba)3 (2.5 mol%)
t-BuXPhos (11 mol%)
MS 3Å, cyclohexane
OMe
MeO
O
NC
O
OMe
MeO
NC
32 (S)-8
O
O P
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OH
O
i-Pr
i-Pr
i-Pr
i-Pr
i-Pr
i-Pr
O
O P
(S)-H8-TRIP
(B)
OH
O
i-Pr
i-Pr
i-Pr
i-Pr
i-Pr
i-Pr
allyl carbonate (3 eq.)
(S)-H8-TRIP (10 mol%)
Pd2(dba)3 (2.5 mol%)
t-BuXPhos (11 mol%)
MS 3Å, cyclohexane,
10 °C, 120 h
OMe
MeO
O
NC
O
OMe
MeO
NC
(63%)
(97% brsm)
ee = 93%32 (S)-8
Entrya) Catalyst Molarity (M) Temperature (°C) 
Time 
(h) 
ee 
1 (S )-TRIP (A)  0.05 rt 18 84 
2 (S )-TRIP (A)  0.025 rt 18 85 
3 (S )-H8-TRIP (B)  0.05 rt 18 86 
4 (S )-H8-TRIP (B)  0.025 rt 36 88 
5 (S )-H8-TRIP (B)  0.01 rt 96 89 
6 (S )-H8-TRIP (B)  0.025 15 96 89 
7b) (S )-H8-TRIP (B)  0.025 15 96 88.5 
8c) (S )-H8-TRIP (B)  0.01 15 120 93 
9d) (S )-H8-TRIP (B)  0.02 10 96 90 
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Crystallographic Data  
All single-crystal X-ray analyses were carried out by Dr. Peter Mayer in the analytic department. The data 
collections were performed on an Oxford Diffraction Xcalibur, Bruker D8Quest or Bruker D8Venture 
diffractometer and MoKα-radiation (λ = 0.71073 Å, graphite monochromator). The CrysAlisPro software 
was applied for the integration, scaling and multi-scan absorption correction of the data. The structures 
were solved by direct methods with SIR97 and refined by least-squares methods against F2 with SHELXL-
97. All non-hydrogen atoms were refined anisotropically. The hydrogen atoms were placed in ideal 
geometry riding on their parent atoms. 
 
Single-crystal X-ray analysis of compound 6. 
 
 
net formula  C12H14O3 
Mr/g mol−1  206.23 
crystal size/mm  0.100 × 0.040 × 0.030 
T/K  100(2) 
radiation  MoKα 
diffractometer  'Bruker D8Venture' 
crystal system  monoclinic 
space group  'C c' 
a/Å  4.2298(2) 
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b/Å  19.7579(11) 
c/Å  12.2515(6) 
α/°  90 
β/°  97.8156(18) 
γ/°  90 
V/Å3  1014.37(9) 
Z  4 
calc. density/g cm−3  1.350 
μ/mm−1  0.096 
absorption correction  multi-scan 
transmission factor range  0.8529–0.9585 
refls. measured  6169 
Rint  0.0331 
mean σ(I)/I  0.0308 
θ range  3.940–26.38 
observed refls.  1631 
x, y (weighting scheme)  0.0465, 0.2317 
hydrogen refinement  constr 
refls in refinement  0.1(15) 
parameters  1775 
restraints  139 
R(Fobs)  2 
Rw(F2)  0.0332 
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Single-crystal X-ray analysis of compound 32. 
 
 
 
 
net formula  C14H15NO3 
Mr/g mol−1  245.274 
crystal size/mm  0.388 × 0.284 × 0.270 
T/K  200(2) 
radiation  'MoKα 
diffractometer  'Bruker D8Quest' 
crystal system  monoclinic 
space group  P21/c 
a/Å  7.2350(2) 
b/Å  11.4719(4) 
c/Å  14.8725(5) 
α/°  90 
β/°  95.298(2) 
γ/°  90 
V/Å3  1229.13(7) 
Z  4 
calc. density/g cm−3  1.32547(8) 
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μ/mm−1  0.094 
absorption correction  ‘multi-scan’ 
transmission factor range  0.8791–0.9144 
refls. measured  19144 
Rint  0.0330 
mean σ(I)/I  0.0212 
θ range  2.75–27.60 
observed refls.  2335 
x, y (weighting scheme)  0.0512, 0.3930 
hydrogen refinement  constr 
refls in refinement  2823 
parameters  165 
restraints  0 
R(Fobs)  0.0438 
Rw(F2)  0.1140 
 
Single-crystal X-ray analysis of compound (rac)-8. 
 
 
 
net formula C17H19NO3 
Mr/g mol−1 285.338 
crystal size/mm 0.17 × 0.14 × 0.12 
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T/K 123(2) 
radiation 'Mo Kα 
diffractometer 'Bruker D8Venture' 
crystal system orthorhombic 
space group P212121 
a/Å 7.6671(6) 
b/Å 8.3382(6) 
c/Å 23.4368(18) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 1498.3(2) 
Z 4 
calc. density/g cm−3 1.26496(17) 
μ/mm−1 0.087 
absorption correction multi-scan 
transmission factor range 0.9276–0.9585 
refls. measured 17807 
Rint 0.0274 
mean σ(I)/I 0.0202 
θ range 3.17–26.43 
observed refls. 2776 
x, y (weighting scheme) 0.0408, 0.3090 
hydrogen refinement constr 
Flack parameter −0.1(10) 
refls in refinement 3051 
parameters 192 
restraints 0 
R(Fobs) 0.0326 
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Single-crystal X-ray analysis of compound 5. 
 
 
 
net formula C19H21NO5 
Mr/g mol−1 343.374 
crystal size/mm 0.483 × 0.451 × 0.356 
T/K 123(2) 
radiation MoKα 
diffractometer 'Oxford XCalibur' 
crystal system triclinic 
space group P1 
a/Å 7.6302(6) 
b/Å 8.8519(6) 
c/Å 12.7508(9) 
α/° 87.503(6) 
β/° 87.653(6) 
γ/° 87.251(6) 
V/Å3 858.75(11) 
Z 2 
calc. density/g cm−3 1.32796(17) 
μ/mm−1 0.096 
absorption correction 'multi-scan' 
 S44 
transmission factor range 0.97201–1.00000 
refls. measured 4728 
Rint 0.0155 
mean σ(I)/I 0.0340 
θ range 4.57–26.37 
observed refls. 2838 
x, y (weighting scheme) 0.0420, 0.2630 
hydrogen refinement constr 
refls in refinement 3462 
parameters 229 
restraints 0 
R(Fobs) 0.0397 
Rw(F2) 0.1023 
 
Single-crystal X-ray analysis of compound 9. 
 
 
net formula C19H22O6 
Mr/g mol−1 346.374 
crystal size/mm 0.182 × 0.095 × 0.054 
T/K 173(2) 
radiation 'Mo Kα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
 S45 
space group P21/c 
a/Å 8.9536(5) 
b/Å 13.8303(7) 
c/Å 13.3248(6) 
α/° 90 
β/° 94.6825(16) 
γ/° 90 
V/Å3 1644.52(14) 
Z 4 
calc. density/g cm−3 1.39901(12) 
μ/mm−1 0.104 
absorption correction multi-scan 
transmission factor range 0.9257–0.9585 
refls. measured 32974 
Rint 0.0386 
mean σ(I)/I 0.0186 
θ range 3.21–26.42 
observed refls. 2795 
x, y (weighting scheme) 0.0414, 0.9448 
hydrogen refinement constr 
refls in refinement 3350 
parameters 229 
restraints 0 
R(Fobs) 0.0378 
Rw(F2) 0.0984 
 
 S46 
Single-crystal X-ray analysis of compound 11. 
 
 
 
net formula C19H23NO5 
Mr/g mol−1 345.38 
crystal size/mm 0.100 × 0.090 × 0.010 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
space group 'P 21/c' 
a/Å 16.1951(7) 
b/Å 8.3508(4) 
c/Å 13.1442(6) 
α/° 90 
β/° 102.4370(10) 
γ/° 90 
V/Å3 1735.93(14) 
Z 4 
calc. density/g cm−3 1.322 
μ/mm−1 0.096 
absorption correction multi-scan 
 S47 
transmission factor range 0.8970–0.9579 
refls. measured 19934 
Rint 0.0461 
mean σ(I)/I 0.0266 
θ range 3.041–25.04 
observed refls. 2472 
x, y (weighting scheme) 0.0407, 0.7699 
hydrogen refinement constr 
refls in refinement 3072 
parameters 229 
restraints 0 
R(Fobs) 0.0353 
Rw(F2) 0.0909 
 
Single-crystal X-ray analysis of compound 16. 
 
 
 S48 
 
net formula C19H23NO5 
C19H23NO5 345.38 
Mr/g mol−1 0.100 × 0.080 × 0.040 
345.38 100(2) 
crystal size/mm MoKα 
0.100 × 0.080 × 0.040 'Bruker D8Venture' 
T/K monoclinic 
100(2) 'C 2' 
radiation 25.0443(7) 
MoKα 6.8179(2) 
diffractometer 10.1504(3) 
'Bruker D8Venture' 90 
crystal system 96.3846(9) 
monoclinic 90 
space group 1722.43(9) 
'C 2' 4 
a/Å 1.332 
25.0443(7) 0.096 
b/Å multi-scan 
6.8179(2) 0.9095–0.9585 
c/Å 16167 
10.1504(3) 0.0317 
α/° 0.0257 
90 3.098–26.43 
β/° 3359 
96.3846(9) 0.0438, 0.6259 
γ/° mixed 
90 0.2(3) 
V/Å3 3536 
1722.43(9) 233 
Z 1 
4 0.0325 
calc. density/g cm−3 0.0785 
1.332 1.057 
μ/mm−1 0.001 
0.096 0.183 
 
C-H: constr 
N-H: refall 
 
 S49 
Single-crystal X-ray analysis of compound 17. 
 
 
net formula C19H23NO5 
Mr/g mol−1 345.390 
crystal size/mm 0.110 × 0.070 × 0.050 
T/K 100(2) 
radiation 'Mo Kα 
diffractometer 'Bruker D8Venture' 
crystal system monoclinic 
space group P21/c 
a/Å 7.6612(4) 
b/Å 20.3093(9) 
c/Å 10.7852(5) 
α/° 90 
β/° 90.6667(15) 
γ/° 90 
V/Å3 1677.99(14) 
Z 4 
calc. density/g cm−3 1.36721(11) 
μ/mm−1 0.099 
absorption correction multi-scan 
transmission factor range 0.9061–0.9585 
refls. measured 19936 
Rint 0.0377 
mean σ(I)/I 0.0301 
θ range 3.33–26.42 
observed refls. 2669 
x, y (weighting scheme) 0.0396, 0.8950 
hydrogen refinement mixed 
 S50 
refls in refinement 3432 
parameters 233 
restraints 0 
R(Fobs) 0.0419 
Rw(F2) 0.1013 
S 1.053 
1.062 0.001 
shift/errormax 0.358 
0.001 −0.190 
 
C-H: constr, N-H: refall. 
 
Single-crystal X-ray analysis of compound S1. 
 
net formula C19H22O6 
Mr/g mol−1 359.416 
crystal size/mm 0.294 × 0.153 × 0.092 
T/K 173(2) 
radiation 'Mo Kα 
diffractometer 'Bruker D8Quest’ 
crystal system orthorhombic 
 S51 
space group Pbca 
a/Å 11.5962(5) 
b/Å 14.1871(7) 
c/Å 21.2925(9) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 3503.0(3) 
Z 8 
calc. density/g cm−3 1.36302(12) 
μ/mm−1 0.098 
absorption correction multi-scan 
transmission factor range 0.9079–0.9580 
refls. measured 61699 
Rint 0.0583 
mean σ(I)/I 0.0202 
θ range 2.46–25.41 
observed refls. 2628 
x, y (weighting scheme) 0.0469, 2.1055 
hydrogen refinement constr 
refls in refinement 3203 
parameters 239 
restraints 0 
R(Fobs) 0.0425 
Rw(F2) 0.1077 
S S 
1.062 1.062 
shift/errormax shift/errormax 
0.001 0.001 
 
 S52 
Single-crystal X-ray analysis of compound 20. 
 
 
net formula C21H27Cl2NO5 
Mr/g mol−1 444.33 
crystal size/mm 0.090 × 0.060 × 0.040 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system triclinic 
space group 'P -1' 
a/Å 8.3263(5) 
b/Å 11.3620(7) 
c/Å 12.3017(6) 
α/° 69.648(2) 
β/° 83.394(2) 
γ/° 70.160(2) 
V/Å3 1026.36(10) 
Z 2 
calc. density/g cm−3 1.438 
μ/mm−1 0.350 
absorption correction Multi-Scan 
transmission factor range 0.7750–0.9705 
refls. measured 12197 
Rint 0.0419 
mean σ(I)/I 0.0483 
 S53 
θ range 3.442–26.372 
observed refls. 3604 
x, y (weighting scheme) 0.0358, 0.7268 
hydrogen refinement H(C) constr, H(O) refall 
refls in refinement 4170 
parameters 269 
restraints 0 
R(Fobs) 0.0403 
Rw(F2) 0.1053 
S 1.035 
shift/errormax 0.001 
max electron density/e Å−3 0.391 
min electron density/e Å−3 −0.447 
 
 
Single-crystal X-ray analysis of compound S2. 
 
 
net formula C20H23NO5 
Mr/g mol−1 357.39 
crystal size/mm 0.100 × 0.090 × 0.070 
T/K 298.(2) 
 S54 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system triclinic 
space group 'P -1' 
a/Å 7.9677(2) 
b/Å 9.2454(2) 
c/Å 11.7448(3) 
α/° 83.4692(8) 
β/° 88.5722(9) 
γ/° 80.9664(9) 
V/Å3 848.88(4) 
Z 2 
calc. density/g cm−3 1.398 
μ/mm−1 0.100 
absorption correction Multi-Scan 
transmission factor range 0.9304–0.9590 
refls. measured 16616 
Rint 0.0285 
mean σ(I)/I 0.0301 
θ range 3.112–27.485 
observed refls. 3287 
x, y (weighting scheme) 0.0585, 0.3339 
hydrogen refinement constr 
refls in refinement 3871 
parameters 238 
restraints 0 
R(Fobs) 0.0485 
Rw(F2) 0.1355 
S 1.070 
shift/errormax 0.001 
max electron density/e Å−3 0.232 
min electron density/e Å−3 −0.218 
 
 S55 
Single-crystal X-ray analysis of compound 21. 
 
 
net formula C27H30N2O6 
Mr/g mol−1 478.53 
crystal size/mm 0.100 × 0.100 × 0.030 
T/K 298.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21/c 1' 
a/Å 13.4422(4) 
b/Å 11.6532(4) 
c/Å 15.2777(5) 
α/° 90 
β/° 99.7940(10) 
γ/° 90 
V/Å3 2358.29(13) 
Z 4 
calc. density/g cm−3 1.348 
μ/mm−1 0.096 
absorption correction Multi-Scan 
transmission factor range 0.9101–0.9590 
refls. measured 45381 
 S56 
Rint 0.0405 
mean σ(I)/I 0.0259 
θ range 3.076–27.494 
observed refls. 4408 
x, y (weighting scheme) 0.0640, 1.3189 
hydrogen refinement mixed 
Flack parameter 5391 
refls in refinement 323 
parameters 0 
restraints 0.0575 
R(Fobs) 0.1627 
Rw(F2) 1.072 
S 0.001 
shift/errormax 0.375 
max electron density/e Å−3 −0.187 
 
 
Single-crystal X-ray analysis of compound 22. 
 
 
net formula C20H22N2O5 
Mr/g mol−1 370.39 
 S57 
crystal size/mm 0.090 × 0.060 × 0.040 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system orthorhombic 
space group 'P b c a' 
a/Å 8.246(5) 
b/Å 18.285(11) 
c/Å 22.344(15) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 3369.(4) 
Z 8 
calc. density/g cm−3 1.461 
μ/mm−1 0.106 
absorption correction Multi-Scan 
transmission factor range 0.9167–0.9590 
refls. measured 4372 
Rint 0.0000 
mean σ(I)/I 0.0439 
θ range 3.648–27.483 
observed refls. 3702 
x, y (weighting scheme) 0.0396, 5.2315 
hydrogen refinement C-H: constr, N-H: refall 
refls in refinement 4372 
parameters 252 
restraints 0 
R(Fobs) 0.0614 
Rw(F2) 0.1544 
S 1.098 
shift/errormax 0.001 
max electron density/e Å−3 0.427 
min electron density/e Å−3 −0.285 
 
 
 S58 
Single-crystal X-ray analysis of compound 29. 
 
 
net formula C24H32N2O8 
Mr/g mol−1 476.51 
crystal size/mm 0.100 × 0.060 × 0.040 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21/c 1' 
a/Å 10.0419(7) 
b/Å 18.4401(10) 
c/Å 12.5503(7) 
α/° 90 
β/° 93.409(2) 
γ/° 90 
V/Å3 2319.9(2) 
Z 4 
calc. density/g cm−3 1.364 
μ/mm−1 0.103 
absorption correction Multi-Scan 
transmission factor range 0.9250–0.9705 
refls. measured 20766 
 S59 
Rint 0.0399 
mean σ(I)/I 0.0339 
θ range 3.252–26.372 
observed refls. 4076 
x, y (weighting scheme) 0.0397, 1.4833 
hydrogen refinement H(C) const, H(N/O) refall 
refls in refinement 4735 
parameters 325 
restraints 0 
R(Fobs) 0.0402 
Rw(F2) 0.1021 
S 1.052 
shift/errormax 0.001 
max electron density/e Å−3 0.360 
 
 
Single-crystal X-ray analysis of compound (R)-8. 
	
 
net formula C17H19NO3 
Mr/g mol−1 285.33 
crystal size/mm 0.10 × 0.10 × 0.09 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system orthorhombic 
space group 'P 21 21 21' 
 S60 
a/Å 7.6599(2) 
b/Å 8.3420(2) 
c/Å 23.4353(7) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 1497.49(7) 
Z 4 
calc. density/g cm−3 1.266 
μ/mm−1 0.087 
absorption correction Multi-Scan 
transmission factor range 0.8862–0.9634 
refls. measured 49074 
Rint 0.0477 
mean σ(I)/I 0.0350 
θ range 3.177–36.36 
observed refls. 6781 
x, y (weighting scheme) 0.0488, 0.2654 
hydrogen refinement constr 
Flack parameter −0.1(2) 
refls in refinement 7261 
parameters 192 
restraints 0 
R(Fobs) 0.0425 	C3:	R		
Single-crystal X-ray analysis of compound (S)-8 
	
 S61 
 
net formula C17H19NO3 
Mr/g mol−1 285.33 
crystal size/mm 0.100 × 0.100 × 0.090 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system orthorhombic 
space group 'P 21 21 21' 
a/Å 7.6610(2) 
b/Å 8.3423(2) 
c/Å 23.4440(5) 
α/° 90 
β/° 90 
γ/° 90 
V/Å3 1498.31(6) 
Z 4 
calc. density/g cm−3 1.265 
μ/mm−1 0.087 
absorption correction Multi-Scan 
transmission factor range 0.9091–0.9666 
refls. measured 66705 
Rint 0.0391 
mean σ(I)/I 0.0270 
θ range 2.997–42.15 
observed refls. 6833 
x, y (weighting scheme) 0.0540, 0.2317 
hydrogen refinement constr 
Flack parameter −0.09(19)  
refls in refinement 7261 
parameters 192 
restraints 0 
R(Fobs) 0.0388 	C3:	S	
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1H NMR (CDCl3, 400 MHz):
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C19H23NO5
M = 345.40 g/mol
13C NMR (CDCl3, 101 MHz):
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1H NMR (CDCl3, 400 MHz):
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C19H23NO5
M = 345.40 g/mol
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13C NMR (CDCl3, 101 MHz):
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M = 329.40 g/mol
13C NMR (CDCl3, 101 MHz):
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13C NMR (CDCl3, 101 MHz):
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13C NMR (CDCl3, 101 MHz):
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M = 478.55 g/mol
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O
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1H NMR (CDCl3, 400 MHz):
21
C27H30N2O6
M = 478.55 g/mol
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 C25H30N2O7
M = 470.52 g/mol
13C NMR (CDCl3, 101 MHz):
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M = 444.53 g/mol
13C NMR (CDCl3, 101 MHz):
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